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2ABSTRACT
Infection of hUlnan cells by bovine adenovirlls type 2 (BAV2) is abortive. To obtain a better
understanding of this pllenomel1011, and in particular to identify Wllich steps in the viral
replicative cycles are altered dllring this virlls-host cells interaction, we have llndertaken a
detailed study of BAV2 infections of the nonpennissive hUlnan IIeLa cells. Using
autoradiography and 3H-thymidine-labeled vvhole virus particles for infection of HeLa cells, vve
determined that viral attachluent appears normal. Furthermore, Southern analysis revealed that
internalization and transport to the nuclells occurs in BAV2 infected HeLa cells. To investigate
viral DNi\ synthesis, infectivity assays involving hydroxyllrea, a viral DN-A synthesis inhibitor,
were carried out. The results revealed that Bft:LV2 DNA synthesis does not occur in HeLa cells.
Fllrtller investigations into viral early gene expression by northern blotting analyses indicated
that HeLa cells fail to support expression of EIA. This suggested that abortive infection by
BAV2 could be attributed to faiiure of EIA to express. To test the possibility that the failure to
express E lA was due to the inability of the host cell to recognize the E lA prOlTIoter, ,ve carried
out transient expression transfection experiments using plaslnids \vith the bacterial lacZ linder
the control of either BAV2 or i\d5 EIA promoter. X-gal histochelIlical assays sho\ved
expression of lacZ from the Ad5 ElA prOlnoter but no expression of lacZ [rOln the BAV2 EIA
prOlTIoter. This further suggests that the abortive infection b:y BAV2 could be attributed to failure
of EIA to express dlle to a nonfllnctional prOlTIoter in hlunan cells. Thus we speClllated that
abortive infection of HeLa cells by adenoviruses may be averted by providing EtA functions in
trans. To demonstrate this, we coinfected HeLa cells with Ad5 and BAV2, reasoning that Ad5
could cOlnpensate for EIA deficiency in BAV2. OUf results showed that BAV2 DNA synthesis
was indeed Sllpported in HeLa cells coinfected with Ad5dlE3 as revealed by Southern analysis.
In contrast, coinfection of HeLa cells \vith BAV2 and Ad5dlElE3 mutallt did not support BLt\V2
DNA synthesis. Interestingly, BAV2 failed to replicate in 293 cells which are constitlltively
expressing the El genes. This could ilnply that El is necessary but not sufficient to avert the
failllre ofBAV2 to undergo productive infection ofhulnan cells.
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1. Literature Review
1.1 Scope of review
Adenoviruses (Ads) have been studied extensively since their discovery in 1953 (Rowe et al.,
1953). These studies have led to a number of very important discoveries both in adenovirus
biology and molecular biology in general. For example, discovery of mRNA splicing was first
reported in Ad system (Berget et aI., 1977). Furthermore, tumor induction in rodents by Ads has
become one of the classical models for studies in oncogenesis (Trentin, 1962). Recently, due to
their highly infectious nature and wide tissue tropism, Ads are being utilized as vectors for gene
therapy and recombinant vaccine development. Abortive infections of Ads is another area that
has been extensively studied for the past 30 years. These studies have contributed not only to the
understanding of biology and evolution of Ads but also to the understanding of oncogenesis by
DNA viruses and functional consequences of DNA methylation in mammalian system. In
addition, studies on abortive infections have great implications in use of Ads as recombinant
viral vectors and gene therapy agents.
This review will discuss most of the known abortive infections by Ads focusing the attention
on viral and cellular determinants that operate to block Ad at different levels of multiplication
cycle. Furthermore, the applications and significance of Ad abortive infections will be explored.
However, in order to completely understand Ad abortive infections one must be familiar with the
events in productive Ad infection. Hence, classification, biology and multiplication cycle of Ads
will be summarized prior to the presentation of Ad abortive infection studies.
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1.2 Classification and epidemiology
The family Adenoviridae contains two genera, Mastadenovirus and Aviadenovirus. While
genus Aviadenovirus contains Ads that infect only birds, the genus Mastadenovirus comprises
human, simian, bovine, equine, porcine, ovine, canine, and opossum viruses (Norrby et al. J
1976). Even though there is antigenic cross-reactivity among members within each genus due to
conserved epitopes located on the hexon protein of the virion, there is no shared specific antigen
common to all Ads (reviewed by Shenk, 1996). Recently, a third phylogenetically different group
of Ads was formed based on analysis of the viral protease genes. This group includes the avian
Egg Drop Syndrome virus -76, bovine Ad type 6, and ovine Ad isolate OAV287 (Harrach et al.,
1997).
1.2.1 Human Ads
Human Ads (Ads) were first isolated by Rowe and colleagues in 1953 from tonsils and
adenoidal tissue surgically removed from children. Soon afterward, similar viral agents were
isolated from feverish military recruits with a variety of respiratory illnesses (Hilleman &
Werner, 1954). Currently, there are 49 distinct serological types of Ads that infect humans.
These agents can infect and replicate at various sites of the respiratory tract as well as in the eye,
gastrointestinal tract, urinary bladder, and liver. Several clinical syndromes have been associated
with Ads including acute respiratory disease, pertussislike syndrome, keratoconjunctivitis, acute
hemorrhagic cystitis, meningoencephalitis, diarrhea and intussusception. The target population of
Ads is primarily children and military recruits (reviewed by Fields, 1996). Recently, these Ads
have been shown to cause fatal, respiratory infection (pneumonitis) in adult transplant recipients
(Simsir et aI., 1998). Although, some Ads experimentally induce tumors in rodents (Trentin,
1962), there is no epidemiologic evidence linking Ads with malignant disease in the human.
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Ads are subdivided into 6 subgenera (A-F) primarily based on their ability to agglutinate red
blood cells (Hierholzer, 1973; Rosen, 1960). Additional sub-classification of Ads is provided
based on viral DNA guanine-cytosine (ae) content, DNA sequence homology and oncogenicity
in rodents (Table 1).
Table 1. Properties of human Ad serotypes of subgenera A-F (modified from Wadell,
1994).
Complete agglutination of monkey 3,7, 11, 14, 16, Moderate + 50-52
erythrocytes 21,34,35
Partial agglutination of rat 1,2,5,6 Low or none + 57-59
erythrocytes
Complete agglutination of rat 8,9,10,13,15,17, Low or none + 57-61
erythrocytes 19, 20, 22-30, 32,
33, 36-39, 42-47
Low or none
4 + 57-59
Unknown :1
40,41
1.2.2 Bovine Ads
Since their first isolation in 1959 (Klein et al. 1959) bovine Ads (BAVs) have been isolated
from a wide variety of hosts that include cattle, sheep (Belak & Palfi, 1974), free living buffalo
(Baber, 1981) and fallow deer (Boros et al., 1985). Currently, there are ten accepted BAV
serotypes, differentiated on the basis of serum neutralization and complement fixation tests. The
ten serotypes are further subdivided into two subgroups based primarily on differences in their
ability to replicate in different cell cultures (Benko et al., 1989), and the lack or presence of
complement-fixing antigen common to Mastadenoviruses (Bartha, 1969). Subgroup 1 contains
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BAVs 1, 2, 3 and 9 that grow in primary bovine testicular or kidney cells as well as in continuous
cell lines and share the antigen common to all Mastadenoviruses. Subgroup 2 contains serotypes
4, 5, 6, 7, 8 and 10 that do not cross-react with any other mammalian Ad in the complement
fixation test, and they can be propagated exclusively in cultures of calf testicular or thyroid cells.
BAVs are associated with respiratory and alimentary tract diseases. Although most infections
are subclinical (Matson et aI., 1988), occasionally BAVs are associated with more serious
diseases such as severe pneumonia, enteritis (Reed et aI, 1978) and epizootic haemorrhagic
enterocolitits (Adair et al., 1966; Smyth et al., 1996).
Bovine Ad type 2 (BAV2) was first isolated by Klein and coworkers in 1959 from the feces of
apparently healthy cattle. BAV2 is subdivided into two subtypes based on restriction
endonuclease mapping and hemagglutination test (Belak et ale 1974). Subspecies A contain
strains of restriction endonuclease patterns similar to the prototype strain No. 19 which
hemagglutinate bovine erythrocytes and infect cattle alone. Subspecies B contains strains closely
related to the strain ORT-111 originally isolated from sheep which hemagglutinate rat
erythrocytes. Besides differences in restriction endonuclease patterns and hemagglutination
properties, subspecies A and subspecies B differ in pathogenicity. Apparently, in lambs, the
ORT-111 strain is more pathogenic than strain No. 19. The stronger pathogenicity of ORT-11l
is demonstrated by the more intensive virus multiplication and shedding, as well as by the more
severe histopathological lesions (Rusvai et al., 1992).
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1.3 Structure
1.3.1 Capsid and core organization
Ads are non-enveloped DNA viruses composed of an icosahedral protein coat called capsid
and an inner DNA protein core (Figure 1). The terminology for structural components of
adenoviral capsid currently used is as established by Ginsberg et al. (1966). The major subunit
of the capsid is a spherical structure called capsomere. The virion has 252 capsomeres, of which
240 capsomeres are called hexons since these appear in a position surrounded by six other
capsomeres. Pentons, on the other hand, are subunits surrounded by five hexons. Each of 12
pentons present in each virion contain a penton base on the surface of the capsid and a fiber
projecting from the base. The fiber is responsible for attachment to cells and for the
hemagglutinating activity of the virus. The fiber length varies with subtypes from 10 nm in
human Ad3 to 50 nm for some fowl Ads (Norrby, 1969).
Ad core structure is composed of double-stranded DNA and four additional viral proteins not
evident in the capsid. The viral DNA is approximately 11 J.lm in length and has a 55-kd terminal
polypeptide covalently linked to each of the 5' ends of the viral genome (reviewed by Horwitz,
1990).
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Figure 1. Model of Ad structure (modified from Stewart et aI., 1991)
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The polypeptide composition of Ads has been determined using Ad2 as the representative
virus (Maizel et a!., 1968; Everitt et al., 1975). The virion contains at least 11 distinct
polypeptide chains separable by electrophoresis on acrylamide gels (Figure 1). These proteins
are numbered II-X by convention and each had been assigned to a specific viral components,
however, the designation for polypeptide I could not be assigned to a single component since the
moiety proved to be a mixture of aggregated smaller molecules (Maizel et al. 1968). The hexon
comprises three tightly associated molecules of 120-kd polypeptide II. The penton base is made
of five molecules of polypeptide III (85 kd), while the fiber is a trimer of three polypeptides IV
(62 kd) (van Oostrum & Burnett, 1985). The conserved amino terminus of the fiber is attached
to the penton base whereas the knob containing the carboxy end projects farthest from the capsid.
Polypeptide V (48.5 kd) is a core protein placed immediumtely internal to the pentons in the
vertex regions of the virion. Polypeptides V, VI (24 kd), VII (18.5 kd), VIII (13kd), J.l, as well as
the 55-kd terminal protein are located within the core of the virion (Hosakawa & Sung, 1976;
Russel et al., 1968).
1.3.2 Genome structure and organization
The Ad genome consists of a single linear, double-stranded DNA which is approximately
11 J.lm in length and varies in molecular weight from 20 to 24 x 106 Da for different serotypes
(Green at al., 1967). The adenoviral DNA has two unique features: (1) it carries a 55kDa
terminal protein (TP) (Robinson et aI, 1973) that is covalently linked via phospodiester bond of
serine 562 to each 5' end and (2) contains relatively short inverted terminal repeats (ITRs)
flanking the coding regions that playa role in replication of the DNA (Arrand & Roberts, 1973).
The GC content ranges from 50-60% and is highest for the most oncogenic serotypes (reviewed
by Green, 1970).
18
Most of the adenoviral genomes that has been sequenced and analyzed to date have similar
general organization. Figure 2 shows a transcription and translation map of Ad2. The viral
chromosome carries five early transcription units (E1A, E1B, E2, E3 and £4), two delayed early
units (IX and IVa2) and one major late unit which is processed to generate five families of late
mRNAs (L1 to L5), all of which are transcribed by RNA polymerase II. Early mRNAs are
transcribed from four distinct regions of the genome (Sharp et al., 1974), two on the r-strand
between 3-14 m.u., and 81-85 m.uo, and two on the I-strand between 58.5-70.7 mou., and 90-94
m.u. (Flint, 1977). Both intermediate and major late units are transcribed by the I-strand of the
viral genome (Persson, 1979; Shaw & Ziff, 1980)0 The transcription and translation of different
Ad regions will be discussed in more detail later in section 104.
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Figure 2. Transcription and translation map of Ad2 (from Horwitz, 1990).
The complete sequence of the BAV2 genome has been deduced and its genetic organization
was deduced by comparing it to human Ads (Ojkic, 1997). Thirty one of the BAV2 protein
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sequences were identified according to their homology to already known Ad polypeptides.
According to these results, the genome organization of BAV2 closely coincides with the genomic
organization of human Ads.
1.4 The life cycle ofAds
The Ad infection is a result of a series of events beginning with the attachments of the fiber to
a host cell receptor, and ending with the assembly of approximately 104 infectious virions per
cell. Studies on the Ad life cycle focused mainly on human Ad2 and 5, particularly their
infection of HeLa and KB cells. The multiplication cycle is divided by convention into two
phases; early and late, with the later commencing with the onset of viral DNA replication (Figure
3). Early events include adsorption, penetration, transcription and translation of an early set of
genes. The late phase begins at the onset of DNA replication with the expression of late viral
genes and assembly of progeny virions. Ad infection has a profound effect on host
macromolecular synthesis as depicted in Figure 3.
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Figure 3. Diagram depicting the major events in the replication cycle of Ad (from Shenk,
1996).
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1.4.1 Adsorption and entry
The initial recognition of the plasma membrane and subsequent virus particle attachment is
mediated by the trimeric viral fiber protein (Philipson et al., 1968). The C-termini of the fiber
polypeptides have been shown to form the distal knob of the protein presumed to bind to the
cellular receptor, while the N-termini form a tail by interacting in a non-covalent manner with the
pentameric penton base (Devaux et aI., 1983). Several observations that the fiber protein length
varies among different serotypes (Signas et al., 1985; Kidd et al. 1993) and that some Ads
contain two fiber genes which provide distinctly different lengths of fiber ( Kidd et al., 1993;
Gelderblom and Maichle-Lauppe, 1982) have led to suggestions that the fiber length is correlated
to the surface density of the cell receptors. Furthermore, the greater fiber length may facilitate
attachment ifbinding to more than one receptor is necessary. The primary receptor CAR for Ad2
and 5 has been recently identified (Bergelson et al., 1997). The same receptor appears to be used
for attachment of Coxsackie B viruses. Since the amino acid sequence of the knob region varies
among serotypes, it is possible that different receptors may be required for different Ad
serotypes.
Internalization of Ad is mediated by a second protein-protein recognition event involving the
penton base and specific members of a family of heterodimeric cell surface receptors, termed
integrins (Wickham et aI., 1993). The interaction occurs through an arg-gly-asp (RGD) sequence
present in the penton base polypeptides (Bai et aI., 1993). The integrins involved appear to be
uvP3 and uvpsvitronectin-binding integrins (Wickham et al., 1993); however, the recognition of
other integrins by the penton base cannot be excluded.
A model for Ad internalization has been proposed (Figure 4). Following attachment via the
fiber protein and its receptor, Ad internalization occurs by receptor-mediated endocytosis. This
process is triggered by the penton-integrin interaction. The precise mechanism by which this
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interaction promotes the entry process is yet to be elucidated; however, the activation of a cell
signaling molecule phophoinositide-3-0H Kinase (PI3K) may play an important role in this
process. It has been demonstrated recently that PI3K is activated upon Ad interaction with (Xv
integrins and that this event is required for Ad internalization (Erguang et aI., 1997). Once taken
up into the cell, the endocytotic vesicle loses the fiber protein and becomes increasingly acidified
as it moves to the cell interior. The change in cytosol pH releases the virion into the cytoplasm
which is accompanied by the loss of the majority of the pentons, protein IX and, apparently, by
proteolysis of protein VI and a sub-population of the hexons (Greber et al. 1993). At this stage
of infection, Ad resembles Ad cores with some of the hexons from the capsid still associated.
The particle then moves to the nuclear pores, where Ad DNA, along with its associated viral core
proteins, is deposited into the nucleus (reviewed by Dulbecco & Ginsberg, 1988). Once inside
the nucleus, the viral DNA presumably associates with cellular histones (Daniell et aI., 1981).
Parental Ad chromatin then binds to the nuclear matrix through its terminal protein initiating
early transcription (Schaack & Shenk, 1989).
2. Internalization
1. Attachment
CYTOPLASM
Figure 4. Diagram showing attachment, entry and uncoating of the Ad particle.
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1.4.2 Early transcription
As demonstrated by studies on Ad2 and Ad5, expression of the early genes begins with the E1
and proceeds in an ordered sequence through the other early transcription units designated E2, E3
andE4.
The E1 domain is divided into the E1A and E1B regions. Transcription ofE1A is controlled
by a constitutively active promoter that includes a duplicated enhancer element (Hearing and
Shenk, 1986). E1A encodes at least five mRNAs, two early and three late. The two early
mRNAs, 13S and 12S, contain identical 5' and 3' ends, differ internally due to differential
splicing, and encode for 289- and 243-amino acid protein respectively (reviewed by Shenk,
1996). These products have a number of functions including: 1) trans-activation and repression
(Borelli et al., 1984; Velcich & Ziff, 1985) ofE1B, E2, E3 and E4 transcription; 2) induction of
host cell to enter S phase of the cell cycle (reviewed by Shenk, 1996); 3) induce high-level
expression of p53 and apoptosis (Clarke et al., 1993; Querido et al., 1997); and 3) oncogenic
transformation of cells in culture (Graham et al., 1974; Ruley, 1983). Unlike certain cellular
factors, the E1A gene products do not appear to bind directly to promoter elements (Lillie &
Green, 1989), suggesting that E1A alone is insufficient to function as a transcriptional activator,
but rather elicits a response through host proteins. The E1A trans-activation occurs as a result of
E1A interactions with different cellular transcription factors and regulatory proteins at the .TATA
motif found 25 to 30 bp upstream of transcriptional initiation sites in many viral and cellular
genes. Although E1A is required to immortalize primary cells in vitro (Graham et al., 1974;
Ruley, 1983), it appears that two E1B proteins are required to maintain the transformed
phenotype in vitro (Byrd et al., 1988). The Ad EIB-55 kd protein probably blocks apoptosis as a
result of its ability to bind to p53 and alter its function (Teodoro and Branton, 1997; Moran,
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1993) while the 19 kd protein, in addition to inhibition of EIA-induced apoptosis modulates
transcriptional properties ofp53 (Sabattini et aI., 1995).
The E2 domain is separated into two different, non-overlapping transcription units called
E2A, and E2B. The jointly controlled E2A and E2B regions code for proteins that are essential
for viral DNA replication. E2A codes for 72kd single-strand DNA-binding protein (DBP)
(Levine et al., 1974). Besides its function in the elongation reaction in DNA synthesis (Horwitz,
1978), the 72kd DBP is also associated with mRNA stability (Babich and Nevins, 1981), host
range (Klessig & Grodzicker, 1979), repression of £4 transcription (Nevins & Jensen-Winkler,
1980) and assembly of infectious virus particles (Nicolas et al., 1983). E2B codes for two
proteins needed for the initiation reaction in DNA replication namely, the 55k Ad terminal
protein (PTP) and the 140 kd Ad DNA polymerase (Ad DNA Pol) (Stillman et al., 1981; Friefeld
et al., 1983). The functions of the E2 proteins will be discussed in section 1.4.3. E2 contains two
promoters; one used early and another late in infection. However, it is not clear why these
promoters switch at different times post infection (Swaminathan and Thimmapaya, 1995).
The E3 region appears to be non-essential for viral growth in tissue culture and can be deleted
without altering viral replication in vitro (Jones & Shenk, 1978). It encodes for proteins that
modulate the host response to Ad infection. Polypeptides 14.7 kd, 14.5 kd and 10.4 kd function
to prevent cytolysis by tumour necrosis factor (TNFa) (Krajcsi et al., 1996). Furthermore, 10.4
kd and 14.5 k Ads been shown to down-regulate the epidermal growth factor (EGF) receptor in
Ad infected cells (Carlin et al., 1989). Another E3 protein (19 kd) interacts with class I MHC
antigens and prevents transport of MHC molecules from the rough endoplasmic reticulum to the
cell surface (Deryckere et aI., 1995). Finally, E3-11.6 kd protein known as Ad death protein
(ADP) appears to be necessary for the effective lysis of infected cells (Tolefson et aI., 1996).
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The E4 regions codes for at least 7 proteins (Dix and Leppard, 1995). Functions encoded by
the Ad E4 region are required for efficient DNA replication, late gene expression, host cell shut-
off and virion assembly. A 34 kd protein has been shown to form a complex with the 55 kd
protein of the E1B region (Samow et al., 1984) in the nucleus. This complex is involved in
transport of viral late mRNAs to the cytoplasm (Omelles & Shenk, 1991). In addition, the 34 kd
protein promotes transformation of primary rodent epithelial cells (Nevels et aI., 1997). The E3-
11kd protein binds to the nuclear matrix and is involved in accumulation of late viral mRNA
(Samow et al., 1982). 19.5 kd E4 protein transactivates the E2 promoter by first activating, along
with E1A, the cellular transcription factor E2F, which then binds to two adjacent sites in the
early E2 promoter (Hemstrom et al., 1991). The protein encoded by E4-orf4 autoregulates its
own transcription by inhibiting Ad E1A-induced activation of E4 transcription (Bondeson et al.,
1996).
1.4.3 DNA Replication
The development of an Ad DNA synthesis system in vitro allowed for the purification and
characterization of the components of the replication system including three viral replication
proteins that include 1) DNA binding protein (DBP), 2) preterminal protein (pTP) and 3) the
adenoviral DNA polymerase (Ad pol) as well as four cellular factors; nuclear factor I (NFl), II
(NFII), III(NFIII), and topoisomerase (reviewed by Shenk, 1996).
According to a novel displacement model for DNA replication (Sussenbach et ala 1972;
Challberg and Kelly, 1979) Ad DNA synthesis can be divided into initiation and elongation
reactions. Initiation begins with the formation of a preinitiation complex. Newly synthesized
DBP molecules form a multimeric protein-DNA complex with viral DNA which in tum changes
DNA configuration to make the binding sites for NFl and Oct-1 (NFIII) accessible (Stuiver et aI.,
1992). The pTP-pol complex, NFl and Oct-1 (NFIII) then bind to their recognition sequences in
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the auxiliary origin oflTR (Figure 5) (Mul and Van der Vliet, 1993). Following the assembly of
this preinitiation complex, the origin of replication is unwound. The precise mechanisms of this
process is not yet identified. Next, initiation occurs when the precursor terminal protein (pTP)
covalently linked to the 5' ends of the viral DNA reacts with dCTP to form a pTP-dCMP
complex. The pTP-dCMP complex then presents the free 3'-OR group in the initiating cytidyl
residue required as a primer for a growing DNA chain (Challbeg et aI., 1980). Synthesis is
initiated at either terminus of the linear DNA; however, only one of the two DNA strands serves
as template for synthesis.
Elongation starts after dissociation of DNA from pTP to enable the DNA to pass freely along
the polymerase (reviewed by van der Vliet, 1995). Elongation is dependent on the DBP as well as
a cellular protein, NFII. DBP facilitates unwinding, enables displacement synthesis, makes the
polymerase highly processive presumably by influencing the DNA structure, and protects newly
synthesized ssDNA (Zijderveld and van der Vliet, 1994; Monaghan et al., 1994; Lindenbaum et
al., 1986; Tsui et al., 1991). The precise function of NFII in Ad DNA chain elongation is not yet
clear although evidence lends support to topoisomerase function (Challberg & Kelly, 1989). As
elongation proceeds the other parental strand that carries pTP becomes displaced as single strand
by the advancing replication fork. The products of replication are a duplex consisting of a
daughter and parent strand plus a displaced single strand of DNA (Figure 6). The fully displaced
parental strand is capable of circularizing by hybridization of the self-complementary terminal
sequences, and the resulting double-stranded "panhandles" that are identical to the ends of the
double-stranded parental genome may be recognized by the same set of initiation proteins. As a
result, the ssDNA can undergo a second round or replication in the same way as the duplex
molecule. Ad DNA replication therefore proceeds by type I replication of duplex strands or type
II replication of the ssDNA molecules (reviewed by Shenk, 1996).
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Figure 5. The Ad type 2/5 origin of DNA replication.
Binding sites for precursor TP-DNA polYlnerase (pTP-pol) in the core origin and for nuclear
factor I (NFl) and NFIII/Oct-l in the auxiliary region are included in the Figure (from Van der
Vliet, 1995).
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Figure 6. General outline of the first round of Ad DNA replication (from Shenk, 1996).
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1.4.4 Late transcription
There are five families of late rnRNAs transcribed at the onset of DNA replication.
Transcription starts from the major late promoter (MLP) and generates a single large
transcriptiol1 llnit whose length is approximately 29,000 bp. This transcript is processed by
differential poly(A) site utilization and splicing to generate at least 18 distinct mRNAs (Figure
2). Based on the utilization of common poly(A) these monocistronic mRNAs are grouped into
five families, termed L1 to L5 (Chow et al., 1977; reviewed by Shenk, 1996). All the late
adenovirallnessenger RNAs carry identical tripartite leader sequence (Nevins & Darnell, 1978).
Following splicing, mRNAs are transported from the nucleus to the cytoplasm and associated
with ribosolnes (reviewed by Shenk, 1996). The cellular transcription contin·ues during late viral
transcription, however, its accumulation in the cytoplasm is blocked. The block is mediated by
the complex formed by the E1B-55 kd and the E4-34 kd polypeptides (Sarnow et al., 1984).
Although it is not precisely understood how this complex inhibits transport of cellular mRNAs, it
has been suggested that it relocalizes a celllliar factor required to transport cellular InRNAs from
their site of synthesis to the nuclear pore (Ornelles and Shenk, 1991).
Late viral mRNAs encode both. structural and non-strllctural proteins. The L1 mRNA codes
for two structurally related proteins, 52 kd and 55 kd whose functions are unkno\vl1, and a hexon
protein IlIa. The L2 mRNA encodes three structural proteins: protein III (penton), the preCllrsor
for protein VII, and protein V. The L3 gene family encodes the precursor for protein VI, protein
II (hexon) and a 23 kd protein. The L4 region encodes a structllral precursor to protein VII
(hexon), a 33 kd protein and a non structural 100 kd protein (Miller et a/., 1980). A 100 kd late
protein functions as a scaffold protein for the assembly of the hexon trimers (Cepko & Sharp,
1983). Finally, the L5 gene family encodes the viral structural protein IV (Fiber) (Miller et al.,
1980).
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Virus-associated RNAs (VA RNA I and II) are also produced at late times of infection;
however, they can he synthesized in the absence of DNA replication. These RNAs are
transcribed in large amounts froin 29 In.ll. on the r-strand of Ad templates by cellular RNA
polymerase III (Soderlund et al., 1976; Celma et al., 1977; Mathews, 1975; Weinmann et ai,
1976). VA RNA I prevents activation of the double-stranded RNA activated inhibitor which
phosphorylates the a-subunit of translation initiation factor eIF-2. Hence, these RNAs are
required for efficient translation of viral proteins (Thimmappaya et aI., 1982; O'Malley et al.,
1989).
Virus assembly begins with formation of capsomers of pentons and hexons in the cytoplasln.
From there on, virus assembly proceeds in the nucleus through a series of intermediates that
encapsidate viral nucleoprotein (consisting of DNA molecliles, TP, pV, pVII and J-l) and
subsequently undergo proteolytic processing to form the final mature particles (reviewed by
Shenk, 1996).
1.5 Host range
Host range of Ads is first determined by the ability of Ad to attach to the host cell. However,
this is not the only criterion that determines the host range of Ads which also depends on the
appropriate intracelllilar interactions of both viral and cellular factors (Lonberg-Holm &
Philipson, 1969). Depending on the extent of Ad multiplication in different cell lines, Ad
infection can be divided in three categories, namely, permissive, semi-permissive and non-
permissive infections. Permissive or productive infections are those in which progeny yield is
maxilnUln. Although selni-permissive infections lead to ne\tv viral progeny, the yield is greatly
reduced as compared to productive infection. Finally, non-permissive or abortive infections are
those in which the virus does not undergo a complete multiplication cycle due to different
intracellular blocks.
29
In general, Ads are species specific and can replicate efficiently in cells derived from their
own species. For example, most Ads (Table 2), with an exception of enteric Ads, grow best in
primary human embryonic kidney (HEK) and continuous malignant human epidermoid
carcinoma cells lines such as cervical (HeLa), laryngeal (Hep-2) and oral (KB) cells (reviewed by
Horwitz, 1996). The 293 and 549 cell lines appear to be good hosts for most Ads including
enteric Ads (Ad40 and Ad41) (Brown et aI., 1992; Hashimoto et al., 1991). The ability of Ads to
grow in various human cell lines varies among serotypes and is suggested to reflect in vivo
tissue-specific susceptibility. For instance, Ad5 is capable of replicating in the cultured human
fetal skeletal myoblasts such as the precursor myoblasts and the multinucleated myotubes (Kohtz
et al., 1991). Furthermore, Ad2, which is pathogenic for certain stratified squamous epithelial
including those of upper respiratory tract and oropharynx, proceeds through a complete
multiplication cycle when used to infect cultured keratinocytes from oropharyngeal sites
(Aneskievich & Taichman, 1988). Infection of cultured human lymphoid cells by Ad type 2 and
5 is also productive (Lavery et aI, 1987).
Not all human Ads replicate efficiently in all cultured human cell lines. Many of these
infections are either semipermissive or abortive (Table 2). For example, enteric Ads in particular
Ad40 and Ad41, grow very poorly in HeLa, KB and HeP-2 cell lines (Pieniazek et aI, 1990).
Furthermore, Ad12 infections of human melanoma cells Nki-4 and human cervical carcinoma
cells C4/1 exhibit a late block (Schwarz et aI, 1982; Kruczek et aI, 1981). Ad2 abortively infects
a number of cell lines including stratified cultures of human epidermal keratinocytes, suprabasal
differentiated cells (Aneskievich & Taichman, 1988) and human peripheral blood lymphocytes
(Horwath et al., 1986). Also, freshly isolated peripheral blood lymphocytes (PBL) are abortively
infected by Ad2 or Ad5 (Schranz et al., 1979).
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Although Ads are species specific the events of cross speCIes infections have been
documented both in animal models and in cell culture. Human Ads, for example, produce
pulmonary disease in cotton rats similar to that of man. Moreover, human Ad5 was found to
infect New Zealand rabbits, chimpanzees and hamsters (reviewed by Horwitz, 1996). Several
additional human adenoviral serotypes extend their host range to the New Zealand rabbits. These
include Adl, 2,5 and 6 (Romanowski et aI., 1998). In cell culture studies, human Ad5 and Ad2
were found to replicate semipermissively in baby hamster kidney cells (BHK21) (reviewed by
Doerfler, 1994). While human Ad5 can efficiently replicate in bovine kidney cells (MDBK)
(Martins, 1995), its replication in mouse cell lines BALB/c 3T3 cells is restricted resulting in at
least 1000-fold lower virus burst compared to human cells (Blair et al., 1989). A number of
abortive infections of human Ads in cell lines of nonhuman origin has been documented. These
include the infection of BHK21 by Ad12 (reviewed by Doerfler, 1994), African monkey cell
lines by Ad2 (Anderson and Klessig, 1982), canine kidney cells (MDCK) by Ad5 (Martins,
1995), hamster embryo cultures (HarnE) by Ad3,-7,-12 or -31 (Shimojo and Yamashita, 1968)
and chinese hamster ovary (CHO) cells by Ad2 (Eggerding and Pierce, 1986). Most of the
abortive infections mentioned above will be further discussed in section 1.6.
Productive infections of human cell lines by animal Ads have not been documented. To date
only one semipermissive infection of human cells by animal Ads has been characterized, namely,
the infection of HeLa cells by mouse Ad F1. HeLa cells infected with F1 produce at least 2000
times less virus than permissive mouse 3T3 cells. The defect in virion production is linked to a
dramatic reduction in the synthesis of AdFl structural proteins, in particular hexon (Antoine,
1982). Two abortive infections of human cell lines by animal Ads have been reported. These are
canine Ad type 2 (CAV-2) infection of human 293, HeLa and KB cells, and ovine Ad (OAV)
infection of a range of human cell types, including lung and foreskin fibroblasts as well as liver,
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prostate, breast, colon, and retinal lines. These infections will be discussed in more detail in
section on Abortive Infections.
Baby hamster Ad2/Ad5 Baby hamster I Ad12
kidney (BHK21) kidney (BHK21)
Mouse BALB/c 3T3 Ad5 Monkey (CV1) Ad2
Mardin-Darbin Ad5
Canine kidney
(MDCK)
Hamster embryo I Ad3/7/12/31
(HarnE)
Chinese hamster I Ad2
ovary (CHO)
HeLa, HEK, HeP-2 I all except Ad40/41
andKB
293 I all
A549 I all
Fetal skeletal I Ad5
myoblasts
Oropharyngeal I Ad2
keratinocytes
Human lymphoid I Ad2/Ad5
cells
Mardin-Darbin I Ad5
bovine kidney
(MDBK)
HeLa, HEK, HeP-2 I Ad41
andKB
serotvne
Human peripheral I Ad2
blood lymphocytes
Table 2: Permissive, semi-permissive and non-permissive infections of various cell lines by Ads.
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1.6 Abortive infections
1.6.1 Early block
1.6.1.1 Ad12 infection ofbaby hamster cells (BHK21)
Human Ad12 infection ofBHK21 cells is abortive. When hamster cells growing in monolayer
cultures are infected with Ad12 at low or at high multiplicity, there is a steady decline of
infectious virus with time after infection. BHK21 cells continue to shed Ad12 particles into the
medium for at least 68 hours post infection. Since, the Ad12 titer does not increase at any time
after inoculation, Ad12 does not complete its multiplication cycle in this cell line (Doerfler,
1970).
Binding, entry and movement of Ad12 to the nucleus appear normal in BHK21 cells.
Independent studies on the efficiency of Ad12 binding to hamster cells showed that
approximately 0.03% to 22.5 % of prelabeled virus inoculum remained associated with BHK21
cells (Doerfler and Lundholm, 1970; Zur Hausen and Sokol, 1969). The wide range observed is
probably due to differences in virus stocks used. Ad12 virions are readily detected by electron
microscopy in the cytoplasm. Approximately, 43% of cell-associated Ad12 DNA can be found in
the nuclear fraction of BHK21 cells 2 h after infection. This is in close agreement with results
obtained in productive infection of Ad12 in KB cells (Doerfler et aI., 1972). However, the
amount of viral DNA in BHK21 nuclei decreases steadily with time after infection, and with
increasing passage number of infected cells (Fanning and Doerfler, 1976).
Early Ad12 mRNA is synthesized from the same early regions expressed during productive
infection. Although, most of the early Ad12 gene products can be synthesized in vitro when
RNA from Ad12-infected hamster cells is used in cell-free translation experiments (Esche, et aI.,
1979; Raska and Strohl, 1972), there are apparent defects in early expression. For example, a 34
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kd protein encoded in the E1A region of Ad12 DNA cannot be translated. It is not known,
whether this is due to failure of the corresponding mRNA to be expressed or to defects in a
translation step (Esche et al., 1979). Moreover, the amount of Ad12 EIA tumor (T) antigen in
BHK cells is approximately 10-15 % of that synthesized in KB cells as revealed by the use of .
anti-peptide antibodies. Also, EtA T antigen synthesis in BHK cells is delayed and starts 12 hour
post infection as opposed to 6 hr in KB cells. The synthesis of the E1B proteins is also decreased
in this system. In particular, the synthesis ofE1B 163R antigen is only 5-10% of that detected in
KB extracts (Lucher, 1990). The decreased levels of EIA and E1B proteins are not due to
differences in protein turnover, since E1A protein stability as determined by pulse-chase
immunoprecipitation is very similar in infected KB and BHK cells (Lucher, 1990). Reduced El
protein synthesis could be attributed to the defects in associated mRNAs, since slot blot northern
analysis indicates that E1A and E1B total RNA concentrations are reduced in abortive infection
(reviewed by Lucher, 1995). It is not known, however, whether this reduction is a result of
decreased transcription or increased RNA turnover in BHK cells.
The levels of early E2 proteins expression are also affected during Ad12 infection of BHK21
cells. The concentration of a DNA binding protein (DBP), for instance, is 120-fold lower in
extracts from infected hamster cells when compared to infected permissive KB cells. This
difference is not a consequence of replication of viral DNA during productive infection, since
this difference is detected in the presence of a DNA synthesis inhibitor, hydroxyurea. In vitro
studies show that DBP isolated from abortive infection maintains the ability to bind the
denatured DNA-cellulose. In addition, BHK297-C131 cells (AdS-transformed carrying the left
18.7% of the AdS genome and express E1 proteins constitutively) that complement the Ad 12
DNA replication defect also stimulate accumulation of the DNA-binding protein even when the
cells are treated with hydroxyurea. Thus, the low concentration of DBP in BHK21 may interfere
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with DNA replication. In contrast, the expression of other E2 products that are necessary for a
successful Ad DNA synthesis, Adpol and pTP, appear to be normal in BHK cells (Lucher,
Khuntirat et aI., 1992). To date, nothing is known about the synthesis of Ad12 E3 or E4 proteins
during Ad12 infection of BHK cells. However, since E3 genes are not required for viral
multiplication in culture, any defect in E3 expression may be irrelevant. On the other hand, it
would be of interest to investigate the level of expression of E4 proteins in abortive infection,
since these are involved in regulating transcription and DNA replication.
BHK21 cells do not allow replication of Ad12 DNA during abortive infection by this virus.
However, crude extracts of BHK cells abortively infected with Ad12 support in vitro formation
of the Ad12 pTP-cCMP initiation complex. The synthesis of the Ad12 pTP-dCMP initiation
complex by BHK extracts is two- to five-fold less than when crude infected human (KB) cell
extracts are used in the reaction. Combining infected KB cytoplasmic and uninfected BHK
nuclear extracts in the reaction suggests that the reduced reaction rate is not a consequence of the
amount of Ad12 pTP and DNA polymerase since it appears to be normal, nor the presence of an
inhibitor in BHK cells. Furthermore, the considerably reduced DBP concentration in BHK21
cytoplasmic extract does not affect the reaction. Rather, the decreased level of pTP-dCMP
complex is probably due to a lesser ability of hamster nuclear extracts to support the initiation
reaction (Lucher, 1990; Cowrira et aI., 1991).
The effects of nuclear factors in this abortive infection have been investigated (Schiedner and
Doerfler, 1996). The binding affinity of NFl factor of BHK21 cells to the ori of Ad12 DNA
appears to be normal. However, NFIII of BHK21 cells has a lower affinity for the ori of Ad12
DNA than for the ori of Ad2 DNA and the levels of NFlII in BHK21 cells are markedly reduced
compared with the levels in permissive human KB cells or complementing BHK297-C 131
hamster cells. These deficiencies are possibly contributing factors for the abortive infection of
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BHK21 hamster cells with Ad12. The lack of sufficient levels of NFlII in BHK21 cells is also
consistent with the decreased replication capacity of Ad2 in hamster compared with human cell
lines (Schiedner et al., 1996).
Transcription of late Ad12 genes in infected hamster cells is defective. Both L1 and VA RNA
are not detected as revealed by Northern blotting and hybridization experiments (Juttermann et
aI., 1989). Ad12-specific L1 and VA RNAs are not synthesized even after the Ad2-transformed
cell line BHK-Ad2E1 is infected with Ad12. This implies that the available E1A viral functions
by themselves are obviously not sufficient for the transcription ofL1 and VA RNAs.
The late transcriptional defect of Ad12 DNA in hamster cells has been attributed to the viral
MLP. The MLP promoter is not functional in Ad12-infected BHK21 cells or AdS-transformed
hamster cells (Weyer and Doerfler, 1985). There is evidence for the presence of a mitigator
element in the first intron following the Ad12 MLP. Removal of this sequence from the Ad12
MLP-CAT plasmid increases the basal activity of the plasmid in uninfected BHK21 and HeLa
during transient expression (Zock an Doerfler, 1990). More importanly, in the absence of the
mitigator, the Ad12 MLP can be activated in BHK21 by Ad12 infection as well as by Ad2
infection, using the authentic transcription initiation site. In conclusion, the mitigator somehow
blocks proper interaction among Ad12 proteins, BHK21 transcription proteins, and Ad12 DNA
to support efficient transcription of the MLP. The Ad2 MLP does not appear to have an
analogous mitigator element.
Complementation experiments have demonstrated the importance of the E1 region in the
mechanism of Ad12 abortive infection. Ad12 DNA replication is supported in BHK21 cells
when coinfected with either Ad2 or AdS (Klimkait and Doerfler, 1985). Ad12, however, does
not yield viral progeny in these coinfection experiments. In the AdS-transformed cell line
BHK21-C131, both Ad12 L1 and VA RNA segments are stably transcribed (Jutterman et aI,
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1989), however, these functions fail to be expressed in the Ad2-transformed hamster cell line
BHK-Ad2E1. This suggests the involvement of cellular functions in abortive infection.
Coinfection of baby hamster cells with Ad12 and AdS dl312 (E1A-minus) or dl313 (E1B-minus)
mutants shows the relative contributions ofE1A and E1B to AdS complementation (Doerfler and
Klimkait, 1987). AdSE1A does not complement Ad12 DNA replication in BHK21, whereas
AdSE1B does. Nevertheless, hamster cell lines transformed by and expressing the AdS E1B
region alone do not support Ad12 DNA replication. These data also suggest that the concerted
action of more than one group of early AdS functions is essential for Ad12 complementation in
hamster cells. During complementation, the AdSE1 may act directly or indirectly on the Ad12
genome. Directly, it can substitute for Ad12 E1 proteins. Ad12 recombinants in which the E1A
and/or E1B are replaced with AdS E1A and/or E1B are viable in human cells (Sawada et a/.,
1988), confirming that AdS E1A and E1B proteins can act directly on Ad12 DNA. Indirectly,
AdSE1 may render the hamster environment suitable for the proper interaction of the Ad12 E1
proteins with the viral DNA and the required cellular components. To date, there is no clear
evidence of such action.
Early after infection of hamster cells with Ad12, integration of Ad12 in cellular DNA has
been observed (Doerfler, 1970). Cellular specific DNA sequence for Ad DNA integration has not
been found (Doerfler et aI., 1983); however, Ad DNA exhibits a preponderance in insertional
recombination at sites of cellular transcriptional activity (Gahlmann et al., 1982; Schulz et al.,
1987). The significance of DNA integration for abortive infection is not known.
;.
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1.6.1.2 Ad 40 infection ofHeLa cells
The fastidious enteric Ad type 40 is found in stool specimens of infants and young children
showing symptoms of gastroenteritis. Ad40 differs from viruses of the other Ad serotypes with
respect to its ability· to grow in tissue culture. While, most human Ads grow well in HeLa cells,
HeLa cells are considered to be nonpermissive for the replication ofAd40 (de long et al., 1983).
Ad40 can be successfully propagated in 293 cells that constitutively express El proteins of
Ad5 and KB-derived cell KB18 and KB6 that express EIB proteins only. Upon infection of
KB18 which expresses EIA only, Ad40 does not grow successfully (Mautner et aI., 1990). It
could be surmised from these experiments, that the early defect in Ad40 infection of HeLa cells
involves the EIB region but not the EIA region.
Mutants of Ad2 and Ad12 with lesions in EIB 55K or 19K protein have been used to further
underline the requirements for Ad40 growth in HeLa cells. Complementation is achieved by
EIB 55K mutant alone, but not 19K alone (Mautner et ale 1990). These results show how Ad40
behaves as a DNA replication-negative EIB 55K mutant and emphasize the regulatory role of the
EIB 55K protein in DNA replication.
The failure of the Ad40 to replicate well in HeLa cells is attributed to the control ofEIB gene
transcription early in infection. Ad40 EIB mRNA is not detectable in cytoplasmic RNA isolated
at early times following infection of either nonpermissive HeLa or permissive KB 16 cells
(Mautner et ale 1990). Since El RNA is not found to accumulate in the nucleus at early times
following infection, the defect is not likely to be in RNA transport. At late times postinfection,
however, both the 22s mRNA encoding 55K and 19K proteins, and the 13s mRNAs encoding the
19K protein, are both easily detectable by northern blot analysis in KB16 cells. However, only
19K proteins are detected in KB 16 cells by antipeptide antisera at late times postinfection. The
lack of early Ad40 EIB mRNA even during complementation implies that complementation in
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293, KB16 is most likely due to substitution of the heterologous E1B for the Ad40 E1B early
during infection.
1.6.1.3 Ad41 infection ofhuman embryofibroblasts (HEF)
Ad40 can successfully propagate in A549 cells which do not have E1B genes (Hashimoto et
al., 1991). E1B mRNAs are detectable in A549 cells early in infection as revealed by dot blot
analysis. These results suggest the presence of cellular factors in A549 cells that can enhance
Ad40 E1B gene expression and/or can help Ad40 DNA replication in the absence of the Ad E1B
55K protein. This further supports the evidence that Ad40 cannot propagate in HeLa cells
because of the failure in E1B gene expression at early times postinfection.
In similar manners to its counterpart Ad40, Ad41 cannot be propagated in cell lines that
permit the efficient replication of other human Ads. In one of those cell lines, namely, human
embryo fibroblasts (HEF), Ad41 undergoes abortive infection due to early block in viral DNA
synthesis (Tiemessen & Kid, 1988). Upon coinfection with permissive Ad2, Ad41 DNA
synthesis is repaired in HEF cells (Tiemessen et al., 1996). The analysis of Ad41-specific
transcripts produced following infection of HEF cells revealed that the only gene region to be
transcribed is that of E1 (0-12 m.u.). These results suggest that the E1 region is not capable of
transactivating expression of other early genes. Further analysis is required to determine
whether this block is due to E1A and/or E1B-specific processes (Tiemessen et aI., 1988).
1.6.1.4 Ovine and canine Ad infection ofhuman cells.
Ovine Ad (OAV), which is phylogenetically distinct from the Mastadenoviruses and.
Aviadenoviruses undergoes abortive infection in a range of human cell types including lung and
foreskin fibroblasts as well as liver, prostate, breast, colon, and retinal lines (Khatri et aI., 1997).
OAV is unable to attach and internalize only in two cell lines, LNCaP (prostate cancer) and 293.
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The attachment and internalization of OAV does not account for the abortive infection in the rest
of the human cells tested. This is surprising since OAV has a fiber protein with a unique cell
binding domain and a penton protein that lacks the integrin-binding Arg-Gly-Asp motif known to
facilitate entry by human Ads. The intracellular block is early at the level of viral DNA synthesis
in these cell lines. OAV promoter activity in various human cell types was assayed by RT-PCR.
Early promoter activity was detectable in some, but not all cell types. For example, early
promoters on the left and right-hand ends (LHPI, LHP2, RH) of the genome as well as those for
E2 and E4 were all active in MRC-5 (human lung fibroblasts). None of the promoters analyzed
was active in HepG2 cells (liver carcinoma) and only the LHP2 (identical to EIA/EIB region of
other Ads) promoter was active in HT29 cells (human colon carcinoma). In addition, major late
promoter activity was not detectable in any cell types. The lack of DNA replication and MLP
function suggests that a critical transition from early to late gene expression does not occur
during abortive infection by OAV (Khatri et al., 1997).
Infection of HeLa, KB and 293 cells by canine Ad type 2 (CAV-2) is nonpermissive. Viral
DNA synthesis does not occur at 10 moi and even at high moi the level of DNA replication is
hardly detectable. Moreover, CAV-2 is not able to generate new viral particles at any moi tested
in these cells. Further studies are needed to determine which viral transcripts are impaired in
CAV2-human cell system (Klonjkowski et al., 1997).
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1.6.2 Late block
1.6.2.1 Ad2 infection ofmonkey cells
Ad2 infection of CV 1 monkey cells is an example of host restriction during the late phase of
infection. Synthesis of early mRNA species from all five major early regions (E1A, E1B, E2, E3
and E4) appears normal in this system. Nevertheless, transcription of late virus-associated RNA
is greatly affected. Although production of VA RNA is identical in productive and abortive
infections of monkey cells, synthesis of VA is significantly greater in HeLa cells than in CV1
cells (Anderson et al., 1985). There are at least three factors believed to contribute to the
reduced concentration of late VA, in this virus-cell interaction. Firstly, the rate of RNA
transcription from the Ad2 MLP is reduced four- to ten-fold and correlates with reductions in
steady-state levels of cytoplasmic RNA. Secondly, reduction in rates of nuclear RNA synthesis
could be attributed in part to premature termination of transcription from the major late promoter.
Although, transcription from the major late promoter of Ad2 prematurely terminates in both
monkey and human cells, it is greatly enhanced in abortive infections of monkey cells (Johnston,
et aI., 1985). Thirdly, Ad infection of monkey cells results in a more efficient attenuation of
RNA initiated 182-188 nucleotides downstream from the MLP transcription start site (Seiberg et
aI., 1989). Interestingly, Ad with mutations in DBP that binds to the attenuated RNA relieve
this restriction. The detailed mechanism of the role of DBP in abortive infection of monkey cells
is still unclear.
Synthesis of fiber protein in CV1 cells abortively infected with Ad2 is at least 100-fold less
than the synthesis of fiber protein in CV1 cells productively infected with a host range mutant of
Ad2 (Ad2hdr400). However, the amount of fiber mRNA present in the cytoplasm of abortively
infected CV1 cells is only five- to ten-fold less than that in productively infected CV1 cells
(Anderson and Klessig, 1983). The reduction in fiber protein synthesis is most likely due to
42
translational defects. In productive infection, 10-25% of the fiber mRNA contain one of the
ancillary leaders x, y, or z, in addition to the common tripartite leader found in all late mRNA. In
abortive infection little or no x or y leader is found on fiber mRNA. The absence of the y leader
decreases translation initiation twofold in abortively infected cells, but the elongation rate during
translation of all fiber mRNA is decreased about threefold, a reduction that is specific for fiber
(Silverman & Klessig, 1989). The late block to Ad2 multiplication in monkey cells is repaired by
coinfection with SV40 or by infection of SV40 large T antigen-expressing monkey cells (Klessig,
1984). Upon coinfection with SV40, normal levels of Ad2 late proteins are synthesized due to
effects on late mRNA metabolism and Ad2 produces new viral progeny (Seiberg et aI., 1989).
1.6.3 Conditional Abortive Infections
1.6.3.1 Ad41 infection of WI-38 cells
Ad41 cannot be cultivated in primary human cell cultures due to blocked DNA replication.
Initially, it was suggested that the lack of growth of Ad41 in human primary cells is the result of
a defect in the Ad41 E1A region (Takiff and Straus, 1982). However, Pieniazek et al. (1990)
demonstrated Ad41 DNA replication in human diploid lung fibroblasts (WI-38) when the serum
concentration in the medium was dropped from 5%-10% down to 0.5%-1%, suggesting the
presence of an inhibitory serum factor. The serum inhibitory effect seems limited to primary
cells because Ad41 replication in 293 cells is not affected by differences in serum concentrations.
Furthermore, this effect appears specific only for Ad41, since conventional AdS, grows well in
both 1 and 10% FBS. The mechanism of serum inhibition does not involve conditional defects
in either E1A or E1B activity, since Ad41 can overcome the multiplication defects of coinfected
AdS dl3l2 and dl3l3 in the presence of 100/0 serum. In addition, Ad41 DNA replication remains
defective in 10% serum during coinfection with dl3l2 or d13l3. The nature of the serum
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inhibitor is not known, nor it is known why it affects only Ad41 multiplication in primary cells
but no continuous cell lines.
1.6.3.2 Ad2 infection ofhuman continuous lymphoid cell lines
Ad2 infection of human continuous T cell line MOLT-3 and a B cell line Raji is another
example of conditional abortive infection (Silver and Anderson, 1988). Almost all MOLT-3 and
Raji cells exposed to Ad2 bind virus, but no more than 5% of the cells show evidence of
infection by DBP or,hexon immunofluorescence. Most of the absorbed virus remain at the cell
surface. In synchronized cell populations, the percentage of cells positive for DBP
immunofluorescence and negative for surface virion capping correlate very well with the
percentage of mitotic cells. Since receptor capping is suppressed during mitosis (Bourguignon et
aI., 1983) only mitotic lymphoid cells appear to be susceptible to Ad2 infection. In conclusion,
the block in resting human lymphoid cells is very early, disrupting internalization of the bound
Ad2, and conditional, being restored at mitosis.
1.7 Applications of abortive infection
Studies on Ad abortive infections can provide us with many answers about the biology of Ads
and viral-cellular factors interactions required for successful Ad multiplication. For example, the
extensively studied abortive infection of BHK21 cells by Adl2 offers insights into the roles of
E1 proteins in infection and the limitations of viral replication due to functional restrictions on a
viral promoter. In addition, as exemplified by Ad40 infection of HeLa-·cells, the roles of EIB
proteins in regulating viral DNA replication may be uncovered. Understanding the late block in
Ad2 infection of African monkey cells may provide some insights in transcription attenuation,
translation and involvement of DBP in Ad infection. Also, conditional abortive infection of WI-
38 cells by Ad 41 may identify serum factors affecting growth of Ads in cell culture. Moreover,
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identification of intracellular blocks in cross-species infections provides an opportunity to study
the evolution of Ads. Analysis of abortive infections is however not only restricted to
understanding Ad biology; it can be also used to study biology of mammalian system. For
example, integration of Ad12 during abortive infection ofBHK21 cells is an attractive model for
investigating mechanisms of foreign DNA integration in mammalian cells, functional
consequences of DNA methylation in eukaryotic system and oncogenicity by DNA viruses.
Abortive infection is also important in considering the use of recombinant Ads as vaccine and
gene delivery vectors. The following sections will review the current strategies and limitations in
adenoviral gene therapy and vaccine development, and discuss the ways in which these
limitations can be partially resolved by analysis and application of nonpermissive infections.
1.7.1 Vaccine development
Ads have been shown to be excellent candidates for constructing recombinant viral vaccines
(Berkner, 1988; Graham, 1990; Graham & Prevec, 1992). Most of the research on use of Ads as
vaccines has been primarily focused on the use of human Ad type 5 and type 2 being the most
extensively studied Ads. To generate recombinant viruses, foreign genes are inserted into the Ad
genome at either E1 or E3 regions (Haj-Ahmad & Graham, 1986; Ghosh-Choudhury et aI.,
1987). Since E3 appears to be non-essential for viral multiplication in both cell culture (reviewed
by Tooze et al., 1981) and animal models (reviewed by Ginsberg et aI., 1989), this region is used
for foreign gene insertion to generate replication-competent recombinant viruses for use as live
recombinant virus vaccines. Many antigenic proteins have been cloned into Ad vectors including
hepatitis B surface or core antigen (Morin et aI., 1987), polyoma middle T antigen (Bernker et
aI., 1987), HIV-1 env, gag, or p24 proteins (Dewar et al., 1989), glycoproteins such as the gB
from herpes simplex virus (McDermott et al., 1989), the respiratory syncytial F protein (Collins
et al., 1990) and glycoprotein D from rabies virus (Prevec et al., 1990). Many of these vectors
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have proven to be effective in conferring both humoral and cellular imlnunity against above
mentioned pathogens in experimental animals.
1.7.1 Gene therapy
The genome structure and biology of human Ads offer a number of advantages for use as
recombinant vectors in gene therapy. These viruses can be easily manipulated and generated in
high titers for in vivo gene therapy but do not integrate into the genome of infected cells
(reviewed by Shenk, 1996). Moreover, human Ads can infect a wide variety of dividing and
qlIiescent cells froln various organs and are able to accommodate relatively large foreign inserts.
Most current recombinant vectors are generated by inserting the therapeutic genes in place of the
essential E1 genes. Such vectors are therefore replication-deficient in the host but can be
prodlIced at high titers using appropriate cOlnplementing cell lines such as 293 (reviewed by
Douglas and Curiel, 1997). Various recolnbinant Ad vectors have been produced for the
development and evaluation of novel gene therapeutics to potentially treat inherited or acquired
diseases. For instance, a recolnbinant Ad5 carrying the human cystic fibrosis transmelnbrane
conductance regulatory gene (CFTR) has been undergoing evaluation in phase I trial that target
cancer and cystic fibrosis (Crystal et al., 1994; Yang et al., 1994). Likewise, Ad vectors
expressing the dystrophy gene are being evaluated for the treatment of neuromuscular diseases
SlICh as Duchenne Muscular Dystrophy (Haeker, 1996). Injection of these vectors into mice
lacking dystrophy gene (lndx) mice induced a correction of the defective phenotype (Acsadi et
al., 1996; Floyd et al., 1998). Hemophilia and hypercholesterolemia are also considered for
treatment with Ad mediated in vivo gene therapy (Yao et aI., 1997). Moreover, Ads were used
to derive the murine or human leptin gene for treatment of obesity in the obese (ob/ob) mouse
model. This treatment is promising since the rate of weight loss and percentage satiety were
significantly reduced in treated Inice. Another disease, mucopolysaccharidosis type VII (Sly
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syndrome) caused by inherited deficiency of the lysosomal enzyme ~-glucuronidase is evaluated
for treatment with Ad gene therapy in a mouse model (Ohashi et al., 1996).
Despite all enthusiasm about the use of Ads in gene therapy, the current gene therapy
protocols have revealed several limitations which seriously impair the success of genetic
treatment with these recombinant viruses. Expression of therapeutic genes appear to be
transient, lasting only three or four weeks (Yang et aI., 1995; Yang et al., 1996). The short-lived
in vivo expression of the transgene is related to the induction of innate and specific host immune
response against the Ad antigen. Worgall and coworkers (1997) were the first to seriously
address the involvement of innate immunity in the elimination of the Ad vectors. They reported
that 90% of the recombinant viral genome is eliminated from the liver 24 hours after intravenous
injection of the vector. This elimination is probably generated by the action of nonspecific liver
macrophages (Kupfer cells) since the transient depletion of these cells partially enhanced both
the persistence of the vectors and delayed their clearance. Despite the deletion of E1, the first
generation Ad vectors were shown to still express late virus genes coding for structural proteins
(Yang et al., 1995; Yang et aI., 1996). This will generate cellular immune responses since newly
synthesized proteins are presented by MHC class I molecules to CD8+ cells, which are activated
to form cytotoxic T lymphocytes. The cytotoxic T cells destroy the vector-infected cells,
resulting in loss of expression of the therapeutic gene and in inflammation. Also, CD4+ helper
cells and B cells are activated by MHC class II presented proteins from the input virus, leading to
production of neutralizing antibodies following primary exposure of the vector. This prevents
the efficient readministration of the vector by binding to the virus and blocking its cellular entry
(reviewed by Douglas et al., 1998).
The current strategies to diminish clearing of Ad vectors by immune system include use of
immunosuppressants such as FK506 (Lockmuller et aI., 1996) and use of monoclonal antibodies
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such as anti-CD4 that block either the T cell receptor or costimulation pathways necessaPj for T
lymphocytes activation (Yang et al., 1996). In addition, in order to prevent expression of late
viral proteins, an isogenic E3-deleted Ad vectors defective in E1 and E2A or El and E4 (Lusky
et al,. 1998) were engineered. However, even in the absence of transgenes, the progressive
deletion of the Ad genome does not extend the in vivo persistence of transduced cells and does
not reduce antivirus immune responses.
1.7.2 Advantages of non-permissive vectors
The restricted host range of Ads can be advantageous in developing recombinant viral
vaccines for a nlunber of reasons. Firstly, the lIse of semi-permissive or non-perinissive Ads as
recombinant vaccines could provide means for decreasing or even eliminating adversed clinical
effects vvhen permissive viruses are used as vaccines. For example, a recombinant vaccine
against rabies has been constructed by engineering Ad5 vector to carry the pseudorabies virus
glycoprotein D. This vaccine has been tested in foxes and skunks (Charlton et al., 1992).
Although the Ad rabies vaccine replicated very poorly in these animals, the protective antibodies
were generated within 4 weeks, without the need for boosters and redundant obvious pathology.
The saIne vaccine has also proven highly effective in producing good levels of rabies-
neutralizing antibodies in dogs and mice (Prevec et al., 1990). In addition to Ad rabies vaccine,
Ad7 recombinant vector carrying multiple hepatitis B antigens has been constructed and used in
dogs (Ye et al., 1991). The Ad hepatitis B vaccine was capable of eliciting antibody response to
all antigens included in the delivery vector (Ye et al., 1991). Recently, canine Ad type 2
(Klonjkowski et al., 1997), ovine Ad (Khatri et aI, 1997) and bovine Ad type 3 (Mittal et al.,
1995; Mittal et al., 1996) have been considered as potential vaccine vectors in animals and
humans. Since, these animal viruses are not known to be pathogenic in humans it would be
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advantageous to use them as recombinant vaccine vectors. However, the capability of such
animal vectors to confer immunity in humans still needs to be investigated.
Another potential application of Ad host restriction in recombinant viral vaccine development
is in the use of nonpermissive Ads as subsequent boosters. Most current Ad vectors are made
from Ad2 and Ad5 (Horwitz et al., 1990). Patients who are seropositive for Ad2 and -5 (and
other subsequent human-derived adenoviral vectors) could be excluded from benefiting from
their potential use. The nonpermissive vectors would be more advantageous in these cases
because they are nonpathogenic and because the host presumably does not have a preexisting
immunity against nonpermissive agents. This was demonstrated by Klonjkowski et al. (1997)
who studied the potential use of canine Ad type 2 (CAV2) as a recombinant viral vaccine and
gene therapy agent. The researchers assayed sera containing "exceptionally" high titers of Ad5
neutralizing antibodies for CAV neutralizing antibodies. At the lowest dilution tested (1/50), five
of the seven samples tested were not able to significantly inhibit CAV2-induced plaques on
permissive cells. The same five samples, on the other hand, were able to inhibit >95% of the
recombinant Ad5 derived vector. In addition to the problem in preexisting immunity against Ad
vectors, the initial immunization with these Ads produces antibodies against the Ad surface
proteins that contain neutralizing epitopes. Hence, it is usually not possible to re-administer the
same serotype and expect sufficient expression of the cloned insert (Yang et al., 1995). The
second Ad serotype carrying the identical foreign gene, to which the host is not immune, is then
used as a booster. Hence, the antigenic diversity of a large number of nonpermissive Ads
provides an extended pool of virus to be used as subsequent boosters.
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1.8 Objectives of the present study
Our lab is interested in the potential use of bovine Ads (BAVs) as recombinant viral vaccines
and gene therapy vehicles. Although foreign genetic material can be easily engineered into
bovine Ads, many factors must be considered in determining their usefulness as viral vectors.
These include host range, stability of the vector, site of replication and mode of replication. The
development of bovine Ad vector entails a precise understanding of the state of the BAV genome
in the infected human cells. The purpose of the present study is to determine the degree of
permissivity of human HeLa cells for BAV2 growth and to identify what aspects of the viral
replicative cycles are altered. In the work described in this thesis, we characterized BAV2
infected HeLa cells with respect to:
1. Viral attachment and internalization
2. Viral DNA synthesis
3. Early viral transcription
4. Activity ofE1A promoter
5. Complementation of BAV2 defects in HeLa cells by coinfection with human Ad5
6. Persistence and stability of viral DNA
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2. MATERIALS AND METHODS
2.1 Recombinant DNA techniques
2.1.1 Bacterial strain
2.1.1.1 Preparation ofcompetent bacteria
Escherichia coli (E. coli) strain DH5-a (Gibco BRL) was used as host in various cloning
experiments described in this study. Bacterial cultures were grown in Luria broth (LB per liter:
10 g bacto-tryptone, 5 g yeast extract, 10 g NaCI, NaOH to pH 7.4). Cells were stored in liquid
medium at 4°C for temporary storage, or in 15% glycerol at -70°C for extended periods of time.
An overnight inoculum of DH5-a was grown in 500 ml of LB broth at 37°C until the OD550
was between 0.45-0.55. The culture was then transferred into 50cc tubes (50 ml/tube) and
centrifuged @ 3500 rpm for 10 minutes at 4°C (IECCentra-8R centrifuge). The supernatant was
discarded and 25 ml of sterile transformation buffer (75 mM CaCl2 and 5mM Tris-HCI, pH7.5)
was added to each tube. The tubes were incubated on ice overnight to make competent cells.
The cells were collected again by centrifugation @ 3500 rpm for 10 minutes at 4°C. Supernatant
was discarded and 1 ml of transformation buffer was added to each tube. Resuspended cells were
frozen in 15% glycerol and stored in 100 J.lI aliquots in small Eppendorf tubes at -70°C.
2.1.2 Plasmids
Several plasmids that were used in the present study were obtained from several sources
(Table 3). Plasmids constructed in this study are described in detail in the Results section.
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Table 3. List of plasmids used for cloning and other purposes in this study
2. 1.3 Enzymes
All enzymes used for cloning purposes were obtained from New England Biolabs (NEB) and
were stored in 50% glycerol at -20°C.
2.1.3.1 Restriction Enzymes
A number of restriction enzymes was used in this study. Restriction enzyme digests were
carried out as suggested by manufacturer of the enzymes. Reaction volume and the amount of
enzyme varied depending on the DNA purity, DNA concentration and type of enzyme used.
Generally, digestions were carried out at 37°C for 2 hours or more. Restriction enzymes were
inactivated by heat inactivation or phenol extraction depending on the type of the enzyme used.
2.1.3.2 Klenow Fragment ofDNA polymerase I
Klenow Fragment of DNA polymerase I was used to fill-in 3' recessed ends produced by
some restriction enzymes. The typical reaction mixture contained DNA at a concentration of 50
J.lg/ml, in one of the four standard NEB buffers (IX) supplemented with 33 J.!M each dNTP and 1
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unit of Klenow per J.lg DNA. The reaction was carried out at room temperature for 15 minutes.
Klenow was inactivated by incubation at 75°C for 20 minutes.
2.1.3.3 Alkaline Phosphatase
Alkaline phosphatase (Calf Intestinal - CIP) removes 5' and 3' phosphoryl groups from
nucleic acids and it was used in cloning procedures to prevent the self-ligation of vector DNA.
The reaction mixture contained vector DNA at a concentration of 0.5J.lg/l OJ.lI in one of the four
standard NEB buffers and 1.0 unit CIP per pmol DNA ends. The reaction was incubated at 37°C
for 60 minutes. CIP was inactivated by phenol extraction and the DNA was recovered by alcohol
precipitation.
2.1.3.4 T4 DNA Ligase
T4 DNA ligase catalyzes the formation of a phospodiester bond between juxtaposed 5'
phosphate and 3' hydroxyl termini in duplex DNA. This enzyme was used for joining blunt-end
and/or cohesive-end termini of vector and DNA fragments that were used in this study. Ligation
was carried out in 20 J.lI volume with appropriate ratio of vector:fragment ratio, IX reaction
buffer (50 mM Tris-HCI, 10 mM MgCI2, 10mM dithiothreitol, 1 mM ATP, 25J.lg/J.lI bovine
serum albumin pH==7.5) and 100 units of T4 DNA ligase. The reaction was incubated at 16°C
overnight.
2. 1.4 Transformation of competent bacteria
About 100 J.lI of a competent bacterial suspension was used for transformation with ligation
reactions not exceeding 20 J.lI volumes. When frozen cells were used, the cells were thawed on
ice. DNA was added to the competent cells and incubated on ice for 30 minutes. To facilitate
uptake of DNA, cells were heat-shocked at 42°C for 45 seconds and immediumtely chilled on ice
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for 3 minutes. Then, 900 J.lI of SOC medium (2% bacto-tryptone, 0.5% yeast extract, 10 mM
NaCl, 2.5 mM KCI, 10 mM MgCI2, 10 mM MgS04 and 20 mM glucose) was added to the cells
and incubated in 37°C water bath shaker for 45-60 minutes to allow expression of antibiotic
resistance genes. Aliquots were plated on LB agar plates that contained ampicillin and X-gal.
The plates were then incubated upside down at 37°C overnight.
2.1.5 Selection
LB agar was made by adding 1.8% agar (Difco) to LB broth and autoclaving to sterilize.
After the agar was cooled down to 50°C, 501J,g/1J,1 of ampicillin and 60IJ,g/J.lI of Xgal (5-bromo-4-
choloro-3-indolyl-p-D-galactopyranoside) was added. Agar was poured onto petri dishes (30
ml/dish), solidified and stored at 4°C.
2.1.6 Small-scale plasmid DNA preparations
Small-scale plasmid DNA preparations were carried out by the modified alkaline SDS lysis
technique of Birnboim and Doly (1978). Individual colonies were picked with a sterile toothpick
and were used to inoculate tubes containing 2 ml of LB broth and ampicillin. The tubes were
incubated in a 37°C water bath shaker overnight. Then, 1.5 ml of overnight cultures were
centrifuged for 30 seconds in a microcentrifuge @ 12,000 rpm (Sorval® MCI2V). The
supernatant was removed by vacuum aspiration and the pellet was then resusupended in 1001J,1
lysing buffer (10mM EDTA, 50mM glucose, 25mM Tris-HCI and 2mg/ml lysozyme, pH8.0).
The tube was incubated for 10 minutes at room temperature then 200 J.lI of alkaline SDS (1 %
SDS and 0.2N NaOH, mixed fresh from concentrated stocks of SDS and NaOH) was added and
mixed gently by inverting the tube several times. After incubation at room temperature for 5
minutes the mixture was neutralized by adding 150 f.ll of 3M sodium acetate (pH4.8) which
precipitates cellular components and denatured macromolecules. The sample was placed on ice
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for 15 minutes and then centrifuged in a microcentrifuge @ 12,000 rpm for 5 minutes. The
supernatant was transferred to a fresh tube to which two volumes of cold 95% ethanol was added.
After incubation at -20°C for 10 minutes the mixture was centrifuged at 12,000rpm for 5
minutes. The ethanol was removed by aspiration and the nucleic acid pellet at the bottom of the
tube was dissolved in 200 J.lI of autoclaved distilled water. DNA was precipitated for a second
time by adding 500 J.lI of cold 95% ethanol and again immediumtely centrifuged. The pellet was
dried for 5-10 minutes at 37°C and dissolved in 100 J.lI of autoelaved TE buffer (10mM Tris-HCI,
1mM EDTA; pH8.0) and stored at 4°C or -20°C.
2. 1.7 Large..scale plasmid DNA preparations
Large-scale plasmid DNA preparations were carried out by using Promega Maxi-Prep Wizard
DNA purification kit. A 500 ml overnight culture was pelleted by centrifugation at 5,000 g for
10 minutes at room temperature (Beckman Avanti™ J-25). The resulting cell pellet was
resuspended in 15 ml of cell resupension solution (50 mM Tris-HCI, 10 mM EDTA, 100mg/ml
RNAse, pH7.5). The cells were lysed by adding 15 ml of cell lysis solution (0.2 M NaOH, 1%
SDS). The solution was mixed gently by inverting the tubes. After the solution became clear
and viscous 15 ml of neutralization solution (1.32 M potassium acetate pH4.8) was added, mixed
and centrifuged at 14,000g for 15 minutes at room temperature. The supernatant was filtered
through filter paper (Whatman #1) and then transferred to a centrifuge bottle. Then, 0.5 volume
of isopropanol was added, mixed by inversion and centrifuged at 14,000g for 15 minutes at room
temperature. The supernatant was discarded and the DNA pellet resuspended in 2ml of TE
buffer. In order to purify the plasmid DNA, 10 ml of Wizard Maxipreps DNA Purification Resin
was added to the DNA solution, mixed and transferred into a Maxicolumn. Vacuum was applied
to pull the resin/DNA mix into the column. 25 ml of column wash solution (80 mM potassium
acetate, 8.3 mM Tris-HCI [pH7.5], 40 mm EDTA in 55% ethanol) and 5 ml of80% ethanol were
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passed through the column respectively. The column was centrifuged at 1,3000g for S minutes at
room temperature to remove ethanol and column wash from the DNA/resin mix. Then, 1.5 ml of
preheated (6S0-70°C) TE buffer was added to the column and incubated for 1 minute. The DNA
was eluted by centrifugation at 1,300g for 5 minutes. In order to completely remove the resin,
the eluate was filtered through a 0.2 mm filter into a clean tube. Plasmid DNA preparations were
stored at 4°C.
2.1.8 Purification of DNA fragments from agarose gels
using Geneclean
Geneclean was carried out according to the supplier's recommendations (Bio 101 Inc).
Restriction enzyme digested DNA fragments were separated on low melting agarose gels. The
desired DNA band was excised from an ethidium bromide-stained agarose gel with a razor blade.
The gel slice was then transferred to a plastic tube to which 3 volumes ofNaI stock solution was
added. The tube was placed in a 4So-S5°C water bath and incubated for about 5 minutes or until
the agarose gel was completely dissolved. S Jll of GLASSMILK suspension was added to
solution containing SJ.lg of less of DNA and incubated on ice for S minutes. The tube was mixed
every 1-2 minutes to keep GLASSMILK in suspension. The silica matrix with the bound DNA
was centrifuged in a microcentrifuge for S seconds. The supernatant was aspirated off and the
pellet was washed by adding 300 J.lI of NEW WASH. The tube was centrifuged from S seconds
and the pellet was washed with NEW WASH two more times (Sorval® MC12V). To elute the
DNA from GLASSMILK the washed pellet was resuspended in 20 JlI of TE buffer or water.
After S minutes of incubation at 4So-SSoC, the tube was centrifuged for SO seconds and the
supernatant was placed to a new tube. Eluted DNA was kept at 4°C or -20°C.
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2.2 Cell culture
2.2.1 eeillines
HeLa is the first aneuploid, epithelial-like cell line to be derived from human tissue and
maintained continuously by serial cell culture. It was isolated from a carcinoma of the cervix of
a 31 year old Negro female (Grey et al. 1952). Human papillomavirus types 16 and 18 sequences
are integrated in HeLa genome (Yee et aI., 1985; Pater et aI., 1985). Since its origin, HeLa has
been one of the most widely studied cell lines. It is used in studies on cytoxicity, cell biology,
transformation, bacterial invasiveness, tumorigenicity and virology. In addition HeLa cells are
used for antitumour testing.
MDBK (Mardin & Darby bovine kidney cells) were derived from a kidney of an apparently
normal adult steer (Mardin et aI., 1958).
293 cell line is a permanent line of primary human embryonal kidney transformed by sheared
human Ad type 5 DNA. The cells are particularly sensitive to human Ad, are highly permissive
for Ad DNA, and contain and express E1 genes of Ad5 (Graham, 1977). The line has been used
in the isolation of transformation defective host range mutants of Ad5 and is excellent for
titrating human Ads.
2.2.2 Propagation and 5ubcultivation
Cell lines were grown on modified Eagle medium (MEM) supplemented with 10% donor
bovine sera or fetal calf sera (Cansera, Rexdale, Ontario), 0.29 mg/ml L-glutamine, 0.225%
sodium bicarbonate and antibiotics [10,000 units/ml penicillin, 25mg/ml amphotericin Band
10,000 mg streptomycin (Gibco BRL)].
All the cells were passaged twice a week when 80-90% confluency was reached. The
medium was removed by aspiration and the cells were washed with phosphate buffered saline
57
once (137 mM NaCI, 2.6 mM KCI, 8.3 mM Na2HP04, 1.5 mM KH2P04, 0.5 mM MgCI2, 0.7
mM CaCI2). 2 ml ofversene (1.4M NaCI, 8.8 mM EDTA, 26 mM KCI, 15mM KH2P04, 15 mM
Na2HP04, 0.2% glucose (w/v)) and 0.5 ml of trypsin (Gibco, BRL) were added to the 120x60
mm dish and incubated at 37°C until the cells in culture partially detached from the bottom of the
dish. After tapping the side of the dish to assist in complete detachment, cells were
immediumtely suspended in the solution. Cells were then transferred to a sterile 25cc tube and
centrifuged @ 1,000 rpm for 5 minutes (IEC Centra-8R Centrifuge). The supernatant containing
the proteolytic enzyme solution was aspirated, and finally proper dilutions were made to be
distributed to fresh petri dishes containing 15 ml of medium supplemented with appropriate
serum and antibiotics.
2.2.3 Cell freezing and thawing
Cell freezing was carried out as outlined by Freshney (1994). Cells were grown up to late log
phase, detached, counted and centrifuged @ 1000 rpm for 5 minutes (IEC Centra-8R Centrifuge).
Cells were then resuspended at approximately 5 x 106 - 2 x 107 cells/ml in fetal bovine or donor
serum containing 10% of dimethyl sulfoxide (DMSO). Cell suspensions were dispensed into 1-
2-ml prelabeled plastic ampules with screw caps. These were then placed at -70°C for up to 1
week after which they were transferred to liquid nitrogen.
Cells were thawed by incubating in a 37°C waterbath. When thawed, they were transferred to
a 120x60 mm plate containing medium supplemented with 10% serum. To remove toxic
DMSO, the medium was changed as soon as cells attached to the plate.
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2.3 Virus culture
2.3.1 Preparation of virus stock
Type of adenoviruses used in this study are shown in Table 4. Virus stocks were prepared as
outlined by Murray (1991). Confluent cell monolayer in 120x60 mm plates was infected with
virus at moi of 0.1-1.0 PFU/cell. The plates were then placed in 370 C incubator for 60 minutes
to allow for virus adsorption. Unadsorbed virus was aspirated, MEM was added, and the plates
were incubated at 37oC. Upon completion of cytopathic effect cells were scraped off the plates
and centrifuged for 10 minutes @ 1,500 rpm (IEC Centra-8R Centrifuge). Supernatant was
removed and the cell pellet was resuspended in 0.5 ml PBS2+ + 10% glycerol/plate. Cells were
alternatively frozen in liquid nitrogen and thawed in a 37°C water bath three times and
centrifuged again @ 1,500 rpm for 10 minutes. Supernatants containing concentrated adenovirus
were stored at -700 C.
Table 4. Adenovirus serotypes used in this study and cell lines adopted for their
propagation
- --I
- :j
-I
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2.3.2 Plaque assay
A modified plaque assay (Murray, 1991) was used to determine the number of infectious Ad
particles. MDBK and HeLa cells were plated in two 6-well plates (35x10 mm) at a density of 10
5 cells/ml or 3 x 10 5 cells/ well and placed at 370 C in the C02 incubator for 24 hours or until
the cell monolayers reached 80-90% confluency. Serial virus dilutions (10-5 - 10-8) were
prepared in PBS2+ in a total volume of 1 ml. The medium in the 6 well plates was aspirated and
the cells were washed 2 times with sterile 1xPBS (1 ml/wash). Then, 0.2 ml of each dilution was
added to triplicate wells of each plate. Plates were placed at 370 C in the CO2 incubator for 1
hour to allow for virus adsorption. To prevent monolayer desiccation and for even virus
distribution plates were tilted at 10 minute intervals. Unadsorbed virus was then aspirated off
and the cells were washed with 1XPBS. Then, 3 ml of overlay containing one volume of
2xMEM supplemented with 1.2 mM MgCl2 and 4% serum, and one volume of 1.2% noble agar)
was added to each well. Following agar solidification the plates were incubated at 370 C.
When plaques became visible the monolayer was fixed by adding 1ml/well of 10% formalin
for 30 minutes. The overlay was then removed and the cells washed with tap water. The cell
monolayer was stained by adding 1 ml/well of 1% crystal violet for 30 minutes. The excess
crystal violet was removed and plaques counted.
In order to estimate the virus titer the dilution with a good number of discrete countable
plaques (20-80) was selected. The mean number of plaques for the three monolayers at that
dilution was multiplied by the reciprocal of the dilution and the reciprocal of the volume added.
The value was expressed as number of plaque forming units (pfu) per m!.
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2.4 Viral DNA and RNA manipulations
2.4. 1 Extraction of viral and cellular DNA
First, the Inediuln was removed by aspiration and the plates were washed with 1 X PBS. Cells
were then trypsinized and washed three times with 1XPBS. Cells were lysed by the addition of a
solution containing 0.01 M Tris-Hel pH7.5, 0.1 M EDTA and 0.4% SDS. Cells were then
transferred to a 15cc tube, proteinase K was added at 100 J.1,g/lnl and incubated at 37°C
overnight. The DNA was then extracted with phenol, 1: 1 phenol-chloroform and chloroform,
respectively. DNA was precipitated by the addition of 0.3 M sodium acetate (pR7.8) and 2
volumes of 95% ethanol. Finally, DNA was washed with 70% ethanol and resuspended in an
appropriate volume of TE buffer.
Approximate DNA concentration was determined by UV absorption at 260 nm. However,
since cellular DNA preparations COllld contain a considerable degree of RNA contalnination the
absolute DNA concentration was lneasured by the diphenylamine reaction.
2.4.2 Extraction of nuclear DNA
Extraction of nuclear DNA was carried out as outlined by Stott (1991). First, the cells were
washed in IXPBS and l1arvested with trypsin. Then, cells \vere pelleted by spinning for 5
minutes at 1000-1500 rpm in a bench-top centrifuge (Sorval® MC12V) and resuspended in 20
lnl ice-cold nuclear isolation buffer (10 InM Tris-HCI pH7.4; 10 mM NaCI; 5mM MgCI2; 1lnM
dithiothreitol; 0.5% Nonidet P-40). The resuspended cells ,vere then incubated on ice for 10
minutes. This step callses lysis of the plasma melnbrane, leaving the nllcleus intact. The nuclei
\vere pelleted by centrifuging at 2,000 rpln at OoC for 5 minutes (IEC Centra-8R Centrifuge).
Nuclei were then washed two to three tilnes in ice-cold nuclear isolation buffer by resllspending.
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gently and centrifuging as outlined above. DNA was then isolated from prepared nuclei by the
same procedure outlined in section 2.4.1.
2.4.3 Diphenylamine Assay
A modified diphenylamine assay (Giles and Myers, 1965) was used to determine the absolute
concentration of DNA stocks. Standard curve was established by a simultaneous assay with
known amounts of herring sperm DNA. Therefore, a set of standard solutions containing 0 -
l0J.lg of herring sperm DNA, and approximately 1-5J.lg of unknown samples (estimated by
measuring OD26o) were diluted in double distilled water to a final volume of 100 J.lI in 1.5 ml
Eppendorf tube. Immediumtely after, the following reagents were added sequentially: 100 J.lI of
20 % perchloric acid (v/v in ddH20), 200 J.lI of 4% diphenylamine (w/v in glacial acetic acid) and
20 J.lI of 0.16 % acetaldehyde (v/v in ddH20). The tubes were vortexed and incubated at room
temperature overnight until a blue colour in the mixture developed. The absorbance of the
samples was determined at wavelength 595 nm using a Hitachi U-2000 spectrophotometer.
2.4.4 Restriction enzyme digestion
Cellular DNA isolated from infected cells was cleaved with the EcoRI restriction
endonuclease. The reaction mixture was performed in a 50-65 J.lI volume. Digestions were
carried out according to the enzyme supplier's recommendations with the following
modifications when digesting viral and cellular DNA: 1.) a two- to threefold excess of enzyme
was used in each reaction, 2) 4mM of spermidine was added to each mixture to increase the
efficiency of digestion and 3) digestions were incubated at 37°C overnight.
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2.4.5 Gel electrophoresis
Gel electrophoresis was carried out using TAE buffer (40mM Tris acetate [pH7.9], 5mM
sodium acetate, and 1 mM Na2EDTA). Agarose gel was made by mixing 1% of agarose (BRL)
with TAE buffer containing 0.25 J-lg/ml w/v of ethidium bromide and boiled until completely
dissolved. The solution was poured on a gel tray after it was cooled down to 50°C. Then, 100/0 of
FLG stopper (50% sucrose, 10mM EDTA, 1% SDS, 0.1% bromophenol blue) was added to
DNA which was then added to the solidified gel placed in the TAE buffer. Viral and cellular
fragments were separated at 20V for 24 hours. A phage DNA HindIII fragments or BRL's l-kb
linear DNA ladder markers were electrophoresed as size standards.
Following electrophoresis gel was visualized under UV light. A clear plastic ruler backed
with masking tape was placed on the side of the gel, and a photograph was taken using a digital
camera.
2.4.6 Southern blotting
A modified Southern transfer technique (Southern, 1975) was used to immobilize DNA
fragments from electrophoresis gels to nitrocellulose membrane. The gel was incubated in 0.25 N
HCI for 15 minutes at room temperature. Gel was then soaked in 0.4N NaOH-0.6M NaCI for 30
minutes and in 1.5M NaCI-0.5M Tris-HCI, pH 7.5 for 1 hour.
A Southern transfer apparatus was made by emerging a sponge into a tray or glass dish filled
with 10 X SSC (3M NaCI, O.3M sodium citrate). The gel was placed on 2 layers of blotting
paper on the surface of the sponge. A nitrocellulose membrane (GeneScreenPlus) which was
soaked in 10X SSC for 15 minutes was placed on top of the gel and all edges were covered with
Saran Wrap. Then, 4-5 pieces of dry filter paper, 2-3 inch stack of absorbent paper towels and
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about 500 g of weight was placed over the membrane. After the transfer, membrane was washed
in 6XSSC, air dried and UV crosslinked.
2.4.7 Nick translation and hybridization technique
Viral and plasmid DNA were labeled by the method of nick-translation, using a commercial
nick-translation system (PROMEGA). Reaction mixture contained 0.5-1 Ilg of purified template
DNA, 5 III lOX nick-translation buffer, 5 III nucleotide mix (300mM stock), 7 III a32P-dATP (35
mCi), 5 Jll nick translation enzyme mix and nuclease-free water to 50 Ill. The reaction was
incubated at 15°C for 1 hour. The entire reaction mixture was used in one hybridization reaction.
Prehybridization and hybridization were carried out at 65°C (Southern blots) or at 62°C
(Northern blots) in a Hybaid hybridization oven. The solution used in prehybridization and
hybridization steps contained 1M NaCl, 1%SDS and 10% Dextran sulfate. The membrane was
prehybridized at 65°C or 62°C for 15-30 minutes. Hybridization was performed overnight in a
hybridization solution supplemented with 100 Ilg denatured Herring sperm DNA and labeled
probe. The membrane was then washed in 2xSSC(w/v) (10 minutes, room temperature), 2xSSC
and 0.1 % SDS (w/v) (1 hour, 65°C or 62°C) and finally with O.lxSSC at room temperature. The
membrane was then placed on a piece of 3MM Whatman paper, in an X-ray cassette containing a
Cronex intensifying screen, covered with Saran wrap and exposed to Kodak X-OMAT X-ray
film for the appropriate period of time.
2.4.8 Extraction of viral & cellular RNA
Infected cell monolayers in 120x60 mm plates were washed three times in PBS. Cells were
lysed by adding 5.2 ml of TRIZOL LS Reagent (Gibco BRL) and incubating for 5 minutes.
Following transfer to 15cc tube, 1.4 ml of chloroform was added to the homogenate, mixed and
incubated at room temperature for 15 minutes. The homogenate was then centrifuged @ 3,000
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rpm (IEC Centra-8R Centrifuge) for 15 minutes and the supernatant containing RNA was
transferred to a fresh tube. Supernatant was then mixed with 3.5 ml of isopropyl alcohol,
incubated at room temperature for 10 minutes and centrifuged for 10 minutes at 3,000g. The
RNA pellet was washed once with 75% ethanol, centrifuged for 5 minutes, dried and
resuspended in an appropriate volume of DEPC-treated water.
RNA preparations were quantitated by measuring the optical density at 260 nm and 280 nm.
Samples with an OD260/280 ratio < 1.7 were reextracted and precipitated since they contained
high content of proteins. The quality of RNA preparations was determined by visualizing 18s and
28s bands on agarose gels.
2.4.9 Northern blot and hybridization
Total RNA mixed with 10% of bromophenol blue was separated by electrophoresis in a 0.9%
agarose-0.1 M sodium phosphate gel @ 50.V for 5 hours. Sodium phosphate buffer (pH6.8) was
made as a 1M solution containing 46.3 ml of 1M Na2HP04 and 53.7 ml of 1M NaH2P04
solutions.
The RNA was transferred to a nitrocellulose membrane as described in Southern analysis but
without pretreatment of the gel in 0.25 N HCI, 0.4N NaOH/0.6 M NaCI and 1.5 M NaCI/0.6 M
Tris-HCl.
2.5 Emulsion autoradiography
2.5.1 In vivo labeling of BAV2
Confluent MDBK cell monolayer in 120x60 mm plates was infected with virus at moi of 0.1-
1.0 PFU/cell. The cells were incubated at 37°C for 60 minutes. The medium was then added to
the infected cell monolayer and again incubated at 37°C. At 6 hr p.i. the medium was removed
and replaced by medium containing 50J.lCi of [3H] thymidine/5 ml. After completion of
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cytopathic effect, the virus was harvested and concentrated as described previously in section
2.3.1.
2.5.2 Infection of cells with fH] labeled virus
Cells were grown overnight directly on pre-cleaned slides which were placed in 120x60mm
plates. The medium was then aspirated and the plate was washed once with 1xPBS. The cell
monolayer was infected with [3H]BAV2 at 10 moi. Slides were taken out from the plates at
various times post infection and washed 3 times with 1xPBS to remove unabsorbed virus.
2.5.3 Fixation of infected cells and autoradiography
The infected cells were fixed by immersion in formalin fixation buffer (0.9 g NaCI, 5 ml
formaldehyde per 100 ml of water; pH7.4) for 4-24 hours. Following fixation the slides were
rinsed in water and dehydrated by successive washing (1 minute each) in the graded ethanol
series (50%, 70%, 95% & 100%). Slides were then washed in xylene for 1 minute and air dried
for about 15 minutes.
In a dark room, under a safe light, slides were dipped in NTB2 nuclear track emulsion
(Kodak) diluted 1:1 with water. The slides were allowed to air-dry in the dark for 1-2 hours after
which they were placed in a box which contained desiccant. The box was wrapped with 2 layers
of aluminum foil and placed at 4°C. The slides were exposed for up to 1 week.
After exposure, the slides were removed from the box and allowed to equilibrate to room
temperature. The slides were developed by immersion in developing solution (Kodak GBX ) for
2-4 minutes, stop bath (water) for 30 seconds and fixative (Kodak GBX) for 4 minutes.
Following fixation the slides were rinsed for 15 minutes in running tap water and allowed to air
dry.
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2.5.4 Counterstaining ofslides
Slides were immersed in hematoxylin solution (Sigma) for 1 minute and then washed in
O.IXSSC for 1 minute and 2X SSC for 15 minutes. The slides were then dehydrated through
graded ethanol solutions (59%, 70%, 95% and 100%) for 1 minute each. Following immersion
in eosin solution (Sigma) for 1 minute the slides were washed three times in 95% and once in
100% ethanol for 1 minute each. The slides were then soaked in xylene, two times for ten
minutes each and mounted in Permount gelatin.
The slides were viewed under a light microscope (Leitz, LABORLUX 11) under 1000x
magnification (oil immersion). The pictures were taken by 35 mm Kodak camera mounted on
the microscope.
2.6 peR procedures
2.6. 1 Primers and reaction conditions for PCR
Primers used in this study were designed by the Cprimer software (Bristol G., and R.
Andersen). The following criteria were used in primer design: 1) primers were 20-28
nucleotides in length, 2) primers contained 50% G+C content, 3) primer pairs have closely
matched melting temperature (Tm) of 60-65°C. Primers were synthesized by Procyon Biopharma
Inc. (London, Ontario).
A typical PCR reaction was carried out in 50 J.lI volume and contained template DNA , 1-2
units Taq DNA polymerase (MBI Fermentas), 5 J.lI of lOX buffer (100 mM Tris-HCI [pH8.8],
500 mM KCI, 0.8% v/v Nonidet P40), 0.2 mM of each dNTP , 1 J.lM of each primer and 1-3 mM
MgCl2 which was optimized for each set of primers.
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2.6.2 Temperature cycling
PCR was carried out in the Single Block Easy Cycler (Ericomp Inc.). Samples were first
denatured for 5 minutes at 94°C. Template DNA was amplified in 35 PCR cycles each
consisting of 45 seconds denaturation at 94°C, annealing for 1 minute @ 65°C and extension for
2 minutes at 72°C. Following the completion of PCR cycles, the final extension was carried out
at 72°C for 10 minutes.
To prepare samples for electrophoresis, 1/10 of the PCR product from each reaction was
mixed with stopper and loaded on 1% agarose gels. Occasionally, the agarose gel electrophoresis
was followed by Southern blotting and hybridization of a specific probe to allow the detection of
a given PCR product in a background of high nonspecific amplification. This was described in
sections 2.3.4 and 2.3.6.
2. 7 DNA Transfection
2. 7.1 Lipofectamine transfection
DNA transfections using lipofectAMINE reagent were carried out according to the
supplier's recommendations (Gibco, BRL). HeLa and 293 cells were plated in two 6-well plates
(35xl0 mm) at density of 10 5 cells/ml or 3 x 10 5 cells/ well and placed at 370 C in the CO2
incubator for 12 hours. For each weIll J.!g of DNA was mixed with serum-free medium to a final
volume of 100 J.!l. In another tube, 2.5 J.!l of lipofectAMINE was diluted in 100 J.!l of serum-free
medium. The two solutions were then combined and the mixture was incubated at room
temperature for 30 minutes. Immediumtely prior to transfection, the cells were washed three
times with serum free medium. Then, 800 J.!l of serum-free medium was added to the tubes
containing DNA-liposomes complexes and this mixture was added onto the washed cell
monolayer. Cells were then incubated at 37°C and 4 hours post transfection 2ml of medium with
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20% serum was added to each well without removing the transfection mixture. The cells were
assayed for lacZ activity 24 hours post transfection by X-gal-based histochemical assay.
2.7.2 Histochemical assay for lacZ activity
This procedure was carried out as outlined by MacGregor et ale (1991). The medium from the
cell monolayer was twice aspirated and rinsed gently and thoroughly with PBS. The cells were
then overlaid with 4% paraformaldehyde fixative (pH7.4) and incubated at room temperature for
5 minutes. The fixative was then aspirated and rinsed 3 times gently with lXPBS. The fixed
cells were then overlaid with X-gal stain (35mM K3Fe(CN)6, 35mM ~Fe(CN)6, ImM MgCI2, in
PBS; pH7.4 supplemented with Img/ml of X-gal) and incubated at 37°C until a blue color
developed. The total number of blue cells was counted under 40X magnification on an inverted
microscope (TelavaI3; Carl Zeiss, West Germany).
2.8 Statistical analysis
Mann-Whitney analyses were performed using SigmaStatTM, version 1.0.
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3. RESULTS
3. 1 SAV2 replication in HeLa cells
Ad permissive infections produce morphological changes in infected cells commonly known
as cytopathic effects (CPEs). In order to examine ifBAV2 infection of HeLa cells is permissive,
we investigated the ability of BAV2 to produce cytopathic effects in this system. This
experiment involved infecting HeLa and MDBK cells with BAV2 at moi's of 1, 10, 100 and
1000 and observing the appearance of cytopathic effect (CPE) by inverted microscopy. Infected
cells from one of these experiments were photographed (Figures 7 and 8). Over a period of 96
hours no CPEs characteristic of Ad infection were observed on HeLa cells infected with BAV2
as cell morphology and appearance remained similar to control noninfected cells (Figure 8).
Permissive MDBK cells were used as a positive control in this experiment. As expected, CPEs
occurred 12 hours pj. in permissive MDBK cells and was complete 48 hours pj. (Figure 7).
While Ad permissive infections produce CPEs, many semipermissive infections, in which
progeny yields are reduced, do not result in CPEs. Hence, to determine whether BAV2 infects
HeLa cells semipermissively or abortively, we compared the production of BAV2 progeny in
HeLa cells to MDBK cells by plaque assay. In this experiment, cells infected with BAV2 at 10
PFU/cell were harvested at 1, 12, 24, 48 and 96 hours pj.. The infected cells were then subjected
to several freeze/thaw cycles to release intracellular virus and infectious virus yields in these
extracts were titered on MDBK cells. The results are presented in Figure 9. As expected, the
infectious virus was observed by 12 hours pj. in MDBK cells and increased exponentially
reaching a maximum at 48 hours pj.. No viral replication was apparent in HeLa cells suggesting
that BAV2 undergoes abortive infection in this system.
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Figure 7: Cytopathic effects in BAV2 infected MDBK cells
Cells were grown on slides overnight and infected at 10 moi. At indicated times pj. slides were
taken out, fixed with formaldehyde and stained with hemotoxylin and eosin. Cytopathic effects
were monitored by inverted microscopy. Magnification, 450X.
A) control (mock infected) MDBK cells
B) 12 hours pj.
C) 24 hours pj.
D) 48 hours pj.
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Figure 8: Absence of cytopathic effects in BAV2 infected HeLa cells
Cells were grown on slides overnight and infected at 10 moi. At indicated times p.i. slides were
taken out, fixed with formaldehyde and stained with hemotoxylin and eosin. Cytopathic effects
were monitored by inverted microscopy. Magnification, 450X.
A) control (mock infected) HeLa cells
B) 12 hours p.i.
C) 24 hours p.i.
D) 96 hours p.i.
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Figure 9. Kinetics of BAV2 replication in MDBK and HeLa cells.
At the indicated times, the cells were scraped into 1ml ofPBS2+, sonicated, and titrated by plaque
assay on MDBK cell monolayers as described in the Materials and Methods.
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3.2 SAV2 attachment to HeLa cells
As in most virus-host cell systems, the infectivity of Ads depends on the availability of
specific cell receptors. If these receptors are absent, Ad fails to internalize. Therefore, the first
test in determining the block of BAV2 multiplication in HeLa cells was to study the ability of
BAV2 to attach to HeLa cells. This was approached by plating MDBK and HeLa cells on slides
and infecting them with 3H labeled BAV2. Slides were taken out 1hr pj. and fixed in
formaldehyde as outlined in Materials and Methods. Following fixation, slides were dipped in
nuclear track emulsion and exposed for 1 week. Slides were then developed, fixed and stained
with hematoxylin and eosin. The slides were examined under a microscope at lOOOX
magnification as outlined in Materials and Methods. Cells were photographed (Figure 10) and
randomly screened for silver grains. The analysis revealed a considerable number of silver grains
in the area surrounding the cells. Therefore, a comparison was made between grain counts over a
given cell to those in background relative to the area of each cell. The results are depicted in
histograms shown in Figure 11. The number of silver grains associated with both HeLa and
MDBK cells was significantly higher than the relative area background count (Mann-Whitney
Rank Sum Test; p==O.05). These results suggested that BAV2 attaches to both HeLa and MDBK
cells.
To compare the relative amount of absorbed virus between HeLa and MDBK cells, number of
silver grains associated with cells was corrected by subtracting the silver grain number over cells
from that in the background. The results shown in Figure 12 revealed that MDBK cells had a
higher number of adsorbed BAV2 particles (Mann-Whitney Rank Sum Test; p==O.05).
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Figure 10: Adsorption of BAV2 particles to HeLa and MDBK cells
Cells were infected with 3H labeled BAV2 at 10 moi and analyzed by emulsion autoradiography
as discussed in the text. Magnification is 2000X.
A) MDBK cells
B) HeLa cells
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The silver grains were counted as indicated in the text. The grain counts are based on the
evaluation of 100 cells (two independent experiments). Error bars denote one standard deviation.
A) MDBK cells
B) HeLa cells
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3.3 SAV2 internalization in HeLa cells
The next step in Ad life cycle involves the internalization of Ad by endocytosis. Since, the
failure of Ad to internalize would result in an abortive infection, it was of interest to study the
internalization of BAV2 in HeLa cells. In this experiment, HeLa cells were infected with BAV2
at 10 moi and 24 hours pj. the cells were trypsinized and washed 2 and 4 times with PBS to
remove the absorbed virus. The total genomic DNA was then isolated, digested with EcoRI,
fractionated on 1% agarose gels and analyzed by Southern Blotting using 32p labeled intact
BAV2 DNA (Figure 13) as probe. The results are shown in Figure 14. Complete BAV2 DNA
sequences were present in HeLa cells following trypsin treatment indicating BAV2
internalization in HeLa cells (Figure 14A; lanes 2 and 3). Amount of BAV2 DNA slightly
decreased following trypsin treatment (Figure 14A; lanes 2 and 3) suggesting that not all
adsorbed virus internalized 24 hours pj.. The densitometric analysis revealed that about 80% of
adsorbed BAV2 particles internalized in HeLa cells 24 hours pj. (Figure 14B).
o
6.5 kb 6.7 kb
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Figure 13: The EcoRI restriction map of BAV2 and a length scale in map units
78
A
c:
"iii
a.
~
....,
o
Z
Trypsin treatment
I I
2xwash 4xwash
Start
A
B
C
D
1 2 3
_______+ --------l-__~_ __j
Trypsin (4xPBS)
1
~ 0.9
~ 0.8
C'O
"~ 0.7
'0 0.6
§ 0.5
~ 0.4
C'O
Q) 0.3
>~ 0.2
&0.1
o ----j--------
No trypsin Trypsin (2x PBS)
Treatment
B
Figure 14: Internalization of BAV2 in HeLa cells
A) Representative autoradiogram showing the effect of trypsin on BAV2 infection of HeLa cells.
The details of the experiment are described in text above. The total genomic DNA was isolated
from infected HeLa cells and analyzed by Southern blotting as outlined in Materials and
Methods. The origin and type of DNA electrophoresed in each slot is described by the respective
abbreviations on top of each lane. A-D on the right side of the Figure show BAV2 DNA
fragments cleaved with EcoRI (see Figure 13). HindIII fragments of A phage DNA were co-
electrophoresed as size markers and their positions are indicated to the left of the Figure.
B) Histogram representing the relative amount of viral DNA estimated by densitometry scanning
of autoradiograms of DNA fragments" The optical density values were normalized to a value of 1
designated for sample in lane 1.
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3.4 SAV2 transport to the nuclei of HeLa cell
To further examine BAV2 abortive infection of HeLa cells the fate of BAV2 DNA was
followed. This was approached by infecting HeLa cells with BAV2 at 10 moi and harvesting
trypsinized infected cells at 1 and 6 hour postinfection. The total genomic DNA was then
isolated from half of the harvested cells, and the other half for nuclear DNA extraction. The
DNA 'was analyzed as described above. The results (Figure 15) showed that no BAV2 DNA
copies were detected in HeLa nuclei 1 hour pj. (Figure 15A; lane 2). However, viral DNA was
clearly detectable in the nuclear fraction 6 hours pj. (Figure 15A; lane 4). Densitometric analysis
showed that approximately 35% of total BAV2 entered the nucleus 6 hours pj. (Figure 15B)
There was an unexpected increase in the copy number of total BAV2 DNA 6 hour pj. (Figure
15A; lane 3). This increase could be attributed to the delay in BAV2 internalization.
3.5 SAV2 DNA synthesis in HeLa cells
The previous experiment showed that BAV2 DNA had a 35% entry rate into the nuclei of
infected cells. This, however, did not indicate whether the detected DNA was from input virus or
newly synthesized. To better understand the phenomenon, infection experiments involving
hydroxyurea (HU), a viral DNA synthesis inhibitor, were carried out. Permissive MDBK
(positive control) and non permissive HeLa cells were infected at 10 moi and treated either with
no drug or with IOmM HU. The total genomic DNA was isolated at various times pj., and
analyzed as described above. The amount of BAV2 DNA increased over time in MDBK cells
not undergoing hydroxyurea treatment (Figure 16A; lanes 1, 2, and 4). Furthermore, hydroxyurea
treatment inhibited BAV2 DNA synthesis in MDBK cells (Figure 16B and 16A; lanes 3 and 5).
There was no apparent change in viral DNA levels in BAV2 infected HeLa cells in the presence
ofHU suggesting that viral DNA synthesis ofBAV2 does not occur in HeLa cells (Figure 17).
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Figure 15: Presence of BAV2 DNA in nuclei of infected HeLa cells.
A) Restriction endonuclease analysis of BAV2 DNA isolated from whole HeLa cells and nuclei
of HeLa cells 1 hour and 6 hour pj. as revealed by the cleavage with EcoRI, by Blotting and
Autoradiography. The origin and type of DNA electrophoresed in each slot is described by the
respective abbreviations on top of each lane. A-D on the right side of the Figure show BAV2
DNA fragments cleaved with EcoRI (see Figure 13). HindIII fragments of A phage DNA were
co-electrophoresed as size markers and their positions are indicated to the left of the Figure.
B) Histogram showing the relative amount of viral DNA expressed in arbitrary units
representing the ratio between the intensity of each lane to the intensity of the lane 3.
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Figure 16: BAV2 DNA synthesis in MDBK cells
24 hr
A) Restriction endonuclease analysis of BAV2 DNA isolated from MDBK cells treated with no
drug or 10 mM hydroxyurea as revealed by the cleavage with EcoRI, by Blotting and
Autoradiography. The origin and type of DNA electrophoresed in each slot is described by the
respective abbreviations on top of each lane. A-D on the right side of the Figure show BAV2
DNA fragments cleaved with EcoRI (see Figure 13). HindIII fragments of A phage DNA were
co-electrophoresed as size markers and their positions are indicated to the left of the Figure.
B) Histogram showing the relative amount of viral DNA expressed in arbitrary units representing
the ratio between the intensity of all lanes to the intensity of lane 4.
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Figure 17: Absence of BAV2 DNA synthesis in HeLa cells.
A) Restriction endonuclease analysis of BAV2 DNA isolated from HeLa cells treated with no
drug or 10 mM hydroxyurea as revealed by the cleavage with EcoRI, by Blotting and
Autoradiography. The origin and type of DNA electrophoresed in each slot is described by the
respective abbreviations on top of each lane. A-D on the right side of the Figure show BAV2
DNA fragments cleaved with EcoRI (see Figure 13). HindIII fragments of A phage DNA were
co-electrophoresed as size markers and their positions are indicated to the left of the Figure.
B) Histogram showing the relative amount of viral DNA expressed in arbitrary units representing
the ratio between the intensity of all lanes to the intensity of lane 3.
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3.6 BAV2 E1A transcription in HeLa cells
The abortive block in BAV2 infection of HeLa cells is at an early stage since BAV2 DNA
synthesis is defective in HeLa cells. One hypothesis that might explain the defect in viral DNA
synthesis is that expression of at least one of the early proteins is affected. Since the E1A
products are needed for efficient transcription of the other viral early genes, transcription of
BAV2 E1A in HeLa cells was investigated.
Permissive MDBK and nonpermissive HeLa cells were infected with BAV2 at 10 moi. Total
RNA was isolated 6 and 24 hours pj. and subjected to agarose gel electrophoresis. The gel was
transferred to a nitrocellulose membrane which was then probed with 32p labeled nt 50-1092
BAV2 fragment isolated from BAV2 E1 containing plasmid pBB12 by HpaI/SnaBI digest
(Figure 18). Figure 19 revealed the presence of E1A RNA species in infected MDBK cells 6
hours (FigureI9A; lane 1) and 24 hours pj. (Figure 19B; lane 1). No EIA specific RNA was
detected in the BAV2 infected HeLa cells 6 hours (Figure 19A; lane 3) or 24 hours pj. (Figure
19B; lane 3).
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Figure 18: Position of 32P-Iabeled pBB12 HpaI/SnaBI fragment used as a probe shown
relative to the EIA and EIB ORFs of BAV2.
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Figure 19: Expression of BAV2 EIA region in infected cells
Northern blot analysis of total RNA isolated from noninfected and BAV2 infected MDBK and
HeLa cells A) 6 hours pj. and B) 24 hours pj. Details of the experiment are outlined in the text
and in Materials and Methods. Each lane contains 10 IJ,g of total RNA. Positions of l8s and 28s
bands as well as predicted position ofElA transcripts are indicated on the left end of the gel.
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3.7 The activity of BAV2 E1A promoter in HeLa cells
3.7.1 Plan of experiments
The previous experiments showed that BAV2 E1A is not expressed in HeLa cells, which
explains why BAV2 DNA cannot replicate in these cells. We then asked the question why E1A is
not expressed in this system. One hypothesis that might explain the defect in viral E1A
transcription is that E1A promoter is not recognized in HeLa cells. This hypothesis was
investigated by directly testing for the activity of the E1A promoter of BAV2 in HeLa cells using
lacZ as a reporter gene. In these experiments, BAV2 E1A promoter was fused with lacZ and in
transient expression assays its activity was tested in HeLa cells. The experiment was controlled
against the E1A promoter of Ad5 fused to lacZ (pE1AlacZ) and a promoterless lacZ plasmid
(pNPlacZ).
3.7.2 Construction ofpB21acZ
A plasmid that contains the reporter gene p-galactosidase coding sequence under the control
ofBAV2 E1A promoter was constructed in this study to assess the innate activity ofBAV2 E1A
promoter in HeLa cells. According to a recent study, the TATA box of the BAV2 E1A promoter
resides at nt 337 (Salmon et aI., 1995). This region is conveniently demarcated by the restriction
site EagI located at nt 363. In the plasmid pdlE1-E, a linker containing a XhoI site and others
was introduced in the same EagI site. This plasmid was therefore the source of the E1A promoter
for the construction of the reporter plasmid (Figure 20). The resulting plasmid, referred to as
pB2lacZ, hence contained nt 1-363 ofBAV2 DNA that served to control the expression of lacZ.
Furthermore, the plasmid also contained the SV40 polyA signal downstream of lacZ.
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3.7.3 Construction of pNPlacZ
Plasmid, pNPlacZ containing ~-galactosidase coding sequence under no promoter was used as
a negative control plasmid in this study. The construction of this plasmid was quite simple and
involved excising BAV2 E1A promoter sequence from pB2lacZ. DNA sequence analysis of
pB2lacZ revealed two convenient restriction sites for removing BAV2 EIA promoter from
pB2lacZ; SnaBI at nt 50 and XhoI at nt 383. Figure 23 illustrates the cloning strategy.
3.7.4 Comparison of the activities of Ad5dlE3 and BAV2 E1A
promoters in HeLa cells
To compare the activities of Ad5 and BAV2 E1A promoters in HeLa cells, HeLa cells were
transfected with expression plasmids pB2lacZ, pE1AlacZ and pNPlacZ as outlined in Materials
and Methods. The activities of the promoters were measured as percentage of HeLa cells
expressing lacZ. The results are represented in a histogram shown in Figure 25 and as
photographs of transfected HeLa cells in Figure 26. Transfection of HeLa cells with pE1AlacZ
resulted in 1.4% of cells expressing lacZ (Figure 25). However, no cells expressing lacZ were
observed after transfection with either pNPlacZ or pB2lacZ (Figures 25 and 26).
3. 7.5 The effects of BAV2 or Ad5dlE3 infection on activity of
Ad5dlE3 and BA V2 E1A promoters in HeLa cells
Although the previous section demonstrated that lacZ under BAV2 E1A promoter control did
not express in HeLa cells, suggesting that BAV2 E1A promoter does not function in these cells,
still we have not excluded the possibility that perhaps the BAV2 E1A-IacZ construct used was
defective to start with. To eliminate this possibility the expression of pB2lacZ in permissive
MDBK cells was tested. Thus, MDBK cells were transfected with four different plasmids;
pCMVlacZ, pNPlacZ, pEl AlacZ and pB2lacZ. Results showed that even upon transfection with
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lacZ under a strong promoter such as CMV on average one in million cells expressed lacZ.
Hence, it was not surprising that no cells expressing lacZ were observed after transfection with
either pNPlacZ or pB2lacZ.
Considering that the above experiments were not conclusive in demonstrating that the lack of
expression of pB2lacZ in HeLa cells was not due to the defective construct, we needed to
conduct a different test. Since, number of adenoviral proteins can act as transactivators, it was
hypothesized that the BAV2 EIA promoter could be activated upon Ad infection. If the Ad
infection resulted in no lacZ expression we could conclude that pB2lacZ was either not properly
constructed or the BAV2 region (0-363 bp) does not include all necessary promoter factors.
However, if pB2lacZ was transactivated by some viral functions, then it would be possible to
implicate that human cell functions are deficient in the recognition of the BAV2 EIA promoter.
In these experiments, HeLa cells were infected with either BAV2 or Ad5dlE3 at 10 moi, 20 hours
after transfection with various lacZ plasmids. The cells were tested for lacZ expression 4 hours
pj.. The results are shown in Figures 27, 28, and 29. After Ad5dlE3 infection of HeLa cells
transfected with control plasmid pE1AlacZ, the percentage of cells expressing lacZ increased by
43% (Figure 27) (Mann-Whitney Rank Sum Test; p==0.05). There was no significant difference
in the pEIAlacZ expression between noninfected or BAV2 infected HeLa cells (Figure 27).
Results further revealed that the pB2lacZ construct was inactive in both uninfected and BAV2-
infected HeLa cells. However, upon Ad5dlE3 infection of HeLa cells transfected with pB2lacZ,
approximately 0.5% of transfeeted cells expressed lacZ. This suggests that Ad5dlE3 was capable
of activating the BAV2 EIA promoter.
40.4°A
...,.---
Amp
Sal 1(4513)
88
.---.------CMV promotor/enhancer
Xho 1(641)
LACZ
Amp'"
Hind III (15317 - '" ./ BAV2 E1A promoter
~~L.....
Hind III (5422)
~"""'---.. ~BAV2 E1A promoter
SV40 polyA
89
Figure 20: Schematic diagram of pB2lacZ construction.
The first step in cloning of pB2lacZ involved construction of the intermediumte plasmid pdlE1-
E-N. The source of the BAV2 E1A promoter was the plasmid pd1E1-E which contained 0-40%
of BAV2 genome with a deletion in E1(1.1-8.2%). This plasmid was cleaved at the XhoI site
(1.2% in the BAV2 sequence) and the ends were treated with alkaline phosphatase. Next, the
XhoI/SaII fragment ofpCMV~-galthat contains the complete beta galactosidase coding sequence
and SV40 polyadenylation signal was gel-purified and cloned into the XhoI site ofpdIE1-E. The
resulting plasmid, pdIE1-E-N contained a BAV2 DNA fragment from 0-40.4% with lacZ gene
in place of deleted E1 and under the control of BAV2 E1A promoter. This plasmid was
confirmed by digestion with several indicative restriction enzymes, followed by separation of the
fragments on a 0.9% agarose gel (Figure 21).
The second step in cloning of pB2lacZ involved deleting BAV2 sequence (10.5-40.4%) from
pdIE1-E-N. This was accomplished by digesting pdIE1-E-N with HindIII and filling the ends
with Klenow polymerase. The plasmid was then religated and used to transform DH5a E.coli.
The restriction enzyme analysis confirmed integrity of the resulting plasmid pB2lacZ which
contained the prokaryotic gene for lacZ with the E1A promoter at the 5' site and SV40-derived
polyadenylation sequences at the 3' end to facilitate translation of the message in eukaryotic cells
(Figure 22).
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Figure 21: Restriction map and restriction endonuclease enzyme analysis ofpdIEI-E-N
A) Restriction map ofpdlElEN was deduced from the DNA sequence analysis using VectorNTI.
B) Restriction enzyme analysis ofpdlElEN.
C) Restriction enzyme digest ofpdlElEN. Plasmid was confirmed by digestion with several
indicative restriction enzymes, followed by separation of the fragments on a 0.9% agarose gel.
Amp, ampicillin resistance gene; LacZ, beta galactosidase coding sequence; CMV, cytomegalo
virus promoter; SV40 poly A, simian virus 40 polyadenylation signal.
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Figure 22. Restriction map and restriction endonuclease enzyme analysis of pB21acZ.
A) Restriction map of pB2lacZ was deduced from the DNA sequence analysis using VectorNTI.
B) Restriction enzyme analysis of pB2lacZ
C) Restriction enzyme digest of pB2lacZ. Plasmid was confirmed by digestion with several
indicative restriction enzymes, followed by separation of the fragments on a 0.9% agarose gel.
Amp, ampicillin resistance gene; LacZ, beta galactosidase coding sequence; CMV, cytomegalo
virus promoter; SV40 poly A, simian virus 40 polyadenylation signal.
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Figure 23. Schematic diagram of pNPlacZ construction.
In order to construct a control plasmid pNPlacZ, pB2lacZ was digested with SnaBI and XhoI
restriction enzymes, positions 0.1-1.1 % in BAV2. Next, the ends were made blunt using Klenow
polymerase and religated.
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Figure 24: Restriction map and restriction endonuclease enzyme analysis of pNPlacZ.
A) Restriction map of pNPlacZ was deduced from the DNA sequence analysis using VectorNTI.
B) Restriction enzyme analysis of pNPlacZ
C) Restriction enzyme digest of pNPlacZ. Plasmid was confirmed by digestion with several
indicative restriction enzymes, followed by separation of the fragments on a 0.9% agarose gel.
Amp, ampicillin resistance gene; LacZ, beta galactosidase coding sequence; CMV, cytomegalo
virus promoter; SV40 poly A, simian virus 40 polyadenylation signal.
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Figure 25. Analysis of AdS and BAV2 EtA promoter activity in HeLa cells.
The graph indicates the percentage of HeLa cells expressing lacZ 24 hours after transfection.
Each value represents the average of two experiments, in which two dishes were used per
experiment. The error bars denote one standard deviation.
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Figure 26 : Photographs of HeLa cells transfected with various lacZ plasmids (lOOX).
A) rEJA;.lacZ B) pB2lacZ and C) p. '. .1acZ.
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Figure 27. Analysis of AdS and BAV2 EtA promoter activity in infected and noninfected
HeLa cells.
The graph indicates the percentage of HeLa cells expressing lacZ 24 hours after transfection.
When Ad infected cells were used, cells were assayed 4 hours p.i. (see text for details). Each
value represents the average of two experiments, in which two dishes were used per experiment.
Error bars represent one standard deviation.
97
A
B
c
Figure 28 :Photographs of AdS infected HeLa cells transfected with various lacZ plasmids
(lOOX).
A) pNPlacZ B) pB21acZ and C) pEl AlacZ.
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Figure 29 :Photographs of BAV2 infected HeLa cells transfected with various IaeZ
plasmids (lOOX).
A) pNPlacZ B) pB2lacZ and C) pEIAlacZ.
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3.8 Complementation of impaired SAV2 functions in
HeLa cells by Ad5dlE3
It is evident from the preceding sections that BAV2 E1A region was not expressed in HeLa
cells, likely because of the ineffectiveness of human cellular factors to activate the E1A
promoter. Since at least 2 E1A products are required during the early phase of infection, it is
likely that the block in E1A transcription in HeLa cells constitute the initial and principal reason
for its failure to infect human cells. An interesting possibility might be that when the block in
E1A expression is removed, then BAV2 might replicate in HeLa cells. To gain a better insight
into this phenomenon, coinfection experiments between human Ad5 and BAV2 in HeLa cells
were carried out.
3.8.1 BAV2 E1A transcription
First, to determine whether the defective BAV2 EIA expression in HeLa cells could be
complemented by Ad5d1E3, northern analysis of the total RNA isolated from infected MDBK
and HeLa cells was carried out. MDBK and HeLa cells were infected with BAV2 alone,
Ad5dlE3 alone or doubly infected with BAV21Ad5dlE3 at moi of 10, and the total RNA was
extracted 12 hours pj.. Total RNA was analyzed by Northern Blotting with 32p labeled E1A
probe (Figure 18). The results in Figure 30 show that BAV2 E1A specific RNA was detected in
MDBK cells infected with BAV2 alone (lane 6) and upon coinfection with Ad5dlE3 (lane 5). As
expected, the E1A probe did not hybridize to total RNA isolated from BAV2 infected HeLa cells
(Figure 30; lane 2); however, BAV2 E1A specific RNA was detected in HeLa cells doubly-
infected with BAV2 and Ad5dlE3 (Figure 30; lane 3). The data clearly demonstrated that
Ad5dlE3 functions could complement the defect in BAV2 EIA transcription in HeLa cells.
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Figure 30: Transcription of BAV2 EtA region in Ad5d1E3/BA V2 doubly-infected HeLa
cells.
Northern blot analysis was carried out on total RNA isolated from BAV2, Ad5dlE3 and
Ad5dlE31BAV2 infected MDBK and HeLa cells. Details of the experiment are outlined in the
text and in Materials and Methods. Each lane contains 10 J.lg of total RNA. Positions of 18s and
28s bands are indicated on the left end of the gel.
3.8.2 BAV2 DNA synthesis
We then determined whether BAV2 DNA replication occurs in HeLa cells upon coinfection
with permissive Ad5d1E3. Thus, HeLa cells were infected with BAV2 alone, and doubly-infected
with Ad5dlE3 and BAV2. At various times pj., as indicated in Figures 32 and 33, the total
DNA was extracted and cut with EcoRI, and fragments were separated by electrophoresis on a
1% agarose gel. After blotting, the Ad5d1E3- and BAV2- specific fragments were detected by
hybridization to 32P-Iabeled pJM17 which contains the complete Ad5dlE3 (Figure 31) or BAV2
DNA followed by autoradiography. The results are presented in Figures 32 and 33. As
previously reported, there was no evidence for the replication of BAV2 in HeLa cells as the
BAV2 DNA copy number remained constant for 72 hours. However, BAV2 DNA replication
was apparent in HeLa cells coinfected with Ad5d1E3. Both BAV2 and Ad5dlE3 DNA replication
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showed the same kinetics in mixed infection (Figure 34). By about 12 hours p.i., BAV2 and
Ad5dlE3 DNA copy number increased by 35% and continued to increase reaching the maximum
at 48 hours p.i. The apparent reduction in viral DNA at 72 hours most likely represents loss of
cells at this time, rather than viral DNA degradation. Comparison of kinetics of Ad5dlE3 DNA
replication in HeLa cells coinfected with BAV2 and HeLa cells infected with Ad5dlE3 alone
revealed some differences. In HeLa cells infected with Ad5dlE3 alone viral DNA synthesis
reached half its maximum in 7 hours as compared to 15 hours in mixed infection (Figure 34).
The slower rate of Ad5dlE3 DNA replication in mixed infection could be due to competition
between Ad5dlE3 and BAV2 over limited cell resources needed for viral DNA replication.
o 25
27.3 kb
50 75
8.7 kb
100 m.ll.
Figure 31: The EcoRI restriction map of Ad5dlE3 and a length scale in map units (m.u.).
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Figure 32: Complementation of the replication defect of BAV2 DNA in human HeLa cells
by coinfection with Ad5d1E3.
Autoradiograms showing restriction endonuclease analysis of BAV2 DNA isolated from HeLa
cells infected with A) BAV2 B) Ad5dIE3/BAV2. Membranes A and B were probed
simultaneously with the same probe and the autoradiograms were exposed for the same period of
time. The origin and type of DNA electrophoresed in each slot is described by the respective
abbreviations on top of each lane. A-D on the right side of the figure show BAV2 DNA
fragments cleaved with EcoRI (see Figure 13). HindIII fragments of A phage DNA were co-
electrophoresed as size markers and their positions are indicated to the left of the figure.
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Figure 33: Replication of Ad5 DNA in human HeLa cells upon infection with Ad5dlE3
alone and coinfection with BAV2
Autoradiograms showing restriction endonuclease analysis of Ad5 DNA isolated from HeLa
cells infected with A) Ad5dlE3 B) Ad5dIE3/BAV2. Membranes A and B were probed
simultaneously with the same probe and the autoradiograms were exposed for the same period of
time. The origin and type of DNA electrophoresed in each slot is described by the respective
abbreviations on top of each lane. A-B on the right side of the figure show Ad5dlE3 DNA
fragments cleaved with EcoRI (see Figure 13).
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Figure 34: Kinetics of BAV2 and Ad5dlE3 DNA replication in HeLa cells
The level of BAV2 and AdS DNA replication was estimated by densitometry scanning of
autoradiograms of DNA fragments (Figures 32 and 33). The intensity of lane 1 hr pj. was
subtracted from the intensity value of other lanes on the gel. The intensity of each lane was then
normalized to an arbitrary percentage with the highest intensity lane being 100%.
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To further show that the increase in BAV2 DNA copIes In doubly-infected BAV2 and
Ad5dlE3 HeLa cells was due to viral DNA synthesis, an experiment involving hydroxyurea was
carried out. In this experiment, HeLa cells simultaneously infected with BAV2 and Ad5dlE3
were treated with no drug or with 10 mM HU previously shown to inhibit BAV2 DNA synthesis
in permissive MDBK cells (Figure 35). The total genomic DNA was isolated at different times
p.i. as indicated in Figure 35. Southern analysis was carried out as discussed above.
Hydroxyurea inhibited BAV2 DNA synthesis at 12 hours p.i. (Figure 35; lane 3) in HeLa cells
coinfected with Ad5dlE3 suggesting that BAV2 DNA synthesis takes place in this system.
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Figure 35: BAV2 DNA synthesis in HeLa cells doubly-infected with BAV2 and Ad5dlE3
A) Autoradiogram showing restriction endonuclease analysis of BAV2 DNA isolated from
doubly-infected HeLa cells treated with no drug or 10 mM hydroxyurea. Details of the
experiment are outlined in the text. The origin and type of DNA electrophoresed in each slot is
described by the respective abbreviations on top of each lane. A-D on the right side of the figure
show BAV2 DNA fragments cleaved with EeoR! (see Figure 13). HindIII fragments of A phage
DNA were co-electrophoresed as size markers and their positions are indicated to the left of the
figure.
B) The bands were analyzed by densitometry scanning. The intensity of lane 1 was subtracted
from the intensity value of other lanes on the gel. The intensity of each lane was then normalized
to an arbitrary value of 1 designated for lane 2.
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3.8.3 BAV2 multiplication
To determine the extent to which Ad5dlE3 complements defective BAV2 infection of HeLa
cells, the possible synthesis of BAV2 virions in double-infected HeLa cells was investigated.
Since MDBK cells are permissive to Ad5dlE3 infection the production of BAV2 virions could
not be tested by titration on MDBK cell layers. Hence, another test was used. In this
experiment, HeLa cells were infected with Ad5dlE3 alone and doubly infected with Ad5dlE3 and
BAV2. Also, MDBK cells were infected with BAV2 serving as a positive control. After
completion of cytopathic effect (72 hours p.i.) infected cells were centrifuged at 6000 rpm for 10
minutes. Following centrifugation, supernatant was spun down at 24,000 rpm for 90 minutes to
collect newly produced virions released by lysed cells. The DNA was then extracted from
virions as described in Materials and methods, digested with XbaI, separated by agarose gel
electrophoresis and transferred to a nitrocellulose membrane. The membrane was probed with
32p labeled BAV2 DNA and 32p labeled pJM17. The results (Figure 36) demonstrated that BAV2
virions replicated in MDBK cells as expected for a permissive system (Figure 36A; lane 1). In
contrast, in HeLa cells doubly infected with Ad5dlE3 and BAV2, there was no evidence for the
presence of newly produced BAV2 virions (Figure 36A; lane 3). On the other hand, Ad5dlE3
virions were produced in both HeLa cells infected only with Ad5dlE3 and those coinfected with
BAV2 (Figure 36B; lanes 2 and 3). Overall, these experiments clearly indicate that Ad5
complementation of BAV2 defects in HeLa cells was such that BAV2 DNA synthesis occurred
but no new virion particles were packaged.
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Figure 36: Absence of newly produced BAV2 virions in HeLa cells coinfected with
Ad5dlE3.
HeLa cells were infected with Ad5dlE3 alone or Ad5dIE3/BAV2 and the production of new A)
BAV2 virions and B) Ad5dlE3 virions was determined as described in the text. BAV2 infected
MDBK cells served as a positive control. The origin and type of DNA electrophoresed in each
slot is described by the respective abbreviations on top of each lane. Letters on the right side of
both Figures show BAV2 and Ad5dlE3 DNA fragments cleaved with XbaI. HindIII fragments of
A phage DNA were co-electrophoresed as size markers and their positions are indicated to the
left of both Figures. <> denotes partially digested BAV2 DNA fragments.
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3.9 Complementation of BAV2 DNA replication in
HeLa cells by functions in the E1 region ofAdS DNA
Our previous experiments clearly demonstrated that BAV2 DNA replication and E1A
transcription which are totally defective in HeLa cells can be elicited by Ad5 functions. Next, we
needed to examine which Ad5 functions are complementing BAV2 defects in HeLa cells.
Number of studies on abortive infections of adenoviruses have shown that the complementing
functions reside mostly in the E1 region of the Ad5 genome (Klimkait et al., 1987; Klimkait et
al., 1985; Mautner et al., 1990; see literature review in this thesis). Hence, the complementing
function of Ad5 E1A region in BAV2/Ad5 infected HeLa cells was examined. In this
experiment, HeLa cells were doubly-infected with BAV2 and a deletion mutant of Ad5 named
Ad5dlEIE3 which carried deletions in the E1 region. The total genomic DNA was isolated at
indicated times post infection (Figure 37) and the BAV2 DNA replication was then investigated
by standard blotting techniques. According to the results presented in Figure 37, Ad5dlEIE3
failed to complement BAV2 DNA replication. In conclusion, the Ad5 function operative in
complementing BAV2 DNA replication was located in the E1 region of Ad5.
3.10 BAV2 DNA replication in 293 cells
Although our results revealed that EI region of Ad5 DNA is responsible for complementing
BAV2 DNA replication in doubly-infected HeLa cells it is not known, however, whether the EI
region is exclusively responsible for complementation. In order to answer this question, BAV2
DNA replication was investigated in 293 cells which constitutively express EI region of Ad5.
Thus, 293 cells were infected with BAV2 and doubly-infected with BAV21Ad5dlElE3 at 10 moi
and the genomic DNA was isolated 1, 24, 48 and 72 hours pj. Southern analysis (Figure 38A)
revealed no increase in BAV2 DNA copy number in BAV2 infected 293 cells over 48 hours pj.
suggesting that BAV2 failed to replicate its DNA in 293 cells. However, BAV2 DNA copy
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number in doubly-infected 293 cells increased 24 hours p.i. and continued to increase reaching
the maximum at 48 hours p.i. (Figure 38B). These results imply that E1 is necessary but not
sufficient to avert the failure ofBAV2 to undergo DNA replication in HeLa cells.
2.3~
2.0~
1 2 3 4
Figure 37: Absence ofBAV2 DNA synthesis in HeLa cells coinfected with Ad5dlE1E3.
Autoradiogram showing restriction endonuclease analysis of BAV2 DNA isolated from 293
cells infected with BAV2. Details of the experiment are outlined in the text above. The origin
and type of DNA electrophoresed in each slot is described by the respective abbreviations on top
of each lane. A-D on the right side of the figure show BAV2 DNA fragments cleaved with
EcoRI (see Figure 13). HindIII fragments of A phage DNA were co-electrophoresed as size
markers and their positions are indicated to the left of the figure.
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Figure 38: BAV2 DNA replication in 293 cells.
Autoradiograms showing restriction endonuclease analysis of BAV2 DNA isolated from 293
cells infected with A) BAV2 B) Ad5dlElE3/BAV2. Details of the experiment are outlined in
the text above. The origin and type of DNA electrophoresed in each slot is described by the
respective abbreviations on top of each lane. A-D on the right side of the figure show BAV2
DNA fragments cleaved with EcoRI (see Figure 13). HindIII fragments of A phage DNA were
co-electrophoresed as size markers and their positions are indicated to the left of the figure.
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3.11 Persistence ofSAV2 genome in infected HeLa
cells prior to passaging
Our previous experiments clearly demonstrated that BAV2 DNA replication is not supported
by HeLa cells, however, the viral DNA was still present in infected HeLa nuclei. Hence, it was
of interest to examine how long this DNA persisted in HeLa cells. Thus, HeLa cells were
infected with BAV2 at 10 moi and harvested at 1, 12, 24, 48, 72 and 96 hours p.i.. The total
genomic DNA was prepared from infected cells, digested with EcoRI, and analyzed as outlined
above. Figure 39 shows that BAV2 genome was present in an intact form in HeLa cells over a
period of 96 hours. Results further revealed that there was no discernible increase in viral DNA
copy number in HeLa cells over a period of 96 hours. This suggests the absence of viral DNA
synthesis in HeLa cells and is in agreement with hydroxyurea experiments discussed earlier.
There was a decrease in viral DNA copy number starting 24 hours pj. (Figure 39A; lane 3),
however, from that point on there was no apparent decrease in BAV2 DNA copy number.
3.12 Persistence ofSAV2 genome in infected HeLa
cells as a result of passaging
Since, BAV2 DNA did not replicate in HeLa cells one could assume that it would eventually
get lost with subsequent cell passaging. To study the effect of passaging on BAV2 DNA
persistence and stability in HeLa cells, infected cells from the above experiment which were
passaged every four days starting at 96 hours pj. and the total genomic DNA was extracted after
1st , 3rd ,sth and 7th passage. DNA analysis was carried out as described above. BAV2
sequences were no longer detectable by high stringency hybridization after the first passage of
infected HeLa or Chang Liver cells (Figure 40; lane 3 ).
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Figure 39. Persistence of BAV2 DNA in HeLa cells
A) Autoradiogram showing restriction endonuclease analysis of BAV2 DNA isolated from
infected HeLa cells. The origin and type of DNA electrophoresed in each slot is described by the
respective abbreviations on top of each lane. A-D on the right side of the figure show BAV2
DNA fragments cleaved with EcoRI (see Figure 13). HindIII fragments of Aphage DNA were
co-electrophoresed as size markers and their positions are indicated to the left of the figure.
B) Histogram showing the relative amount of viral DNA expressed in arbitrary units representing
the ratio between the intensity of all lanes to the intensity of lane 4.
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Figure 40: Effect of passage number on persistence of BAV2 genome in HeLa cells.
A) Autoradiogram showing restriction endonuclease analysis of BAV2 DNA isolated from
infected HeLa cells. Details are explained in the text. The origin and type of DNA
electrophoresed in each slot is described by the respective abbreviations on top of each lane. A-
D on the right side of the figure show BAV2 DNA fragments cleaved with EcoRI (see Figure
13). EcoRI fragments ofBAV2 DNA (lane 1) were co-electrophoresed as size markers and their
positions are indicated to the left of the figure.
3.13 Persistence of E1A region in passaged HeLa
cells
Since, southern blot analysis has limited sensitivity in detecting very low levels of copies per
cell, DNA from passaged infected HeLa cells was further analyzed by peR. In this experiment,
BAV2 EIA region (Figure 41) was amplified in IJ.lg of infected HeLa DNA extracted at various
passages. Amplified DNA was subjected to agarose gel electrophoresis. Figure 42A shows the
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results of the amplification. The amplified fragments were ~920 bp and were found in BAV2
control DNA and in HeLa DNA passaged up to 5 times.
To further identify the amplified products as BAV2 E1A region, the same gel was transferred
to a nitrocellulose membrane and probed with BAV2 E1A HpaI/SnaBI fragment isolated from
pBB12 (Figure 42B). This analysis confirmed the presence of BAV2 E1A region in cells
passaged up to 5 times (Figure 42B; lanes 4-6). However, BAV2 EtA region disappeared after
7th passage of infected HeLa cells (Figure 42B; lane 7).
nt478
, ,
5 AlGAGGCACTIGGCITACl:
3'------
Figure 41: peR primers used to amplify BAV2 EIA region
------3'
AGCXXXITTCAACCACCAGAT 5'
+nt1398
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Figure 42: Persistence of BAV2 EIA region in passaged HeLa cells
A) Photograph of the ethidium bromide stained agarose gel showing amplified BAV2 E1A
region (478-1398 bp) in 1J.lg of infected HeLa DNA isolated at various passages. The origin and
type of DNA electrophoresed in each slot is described by the respective abbreviations on top of
each lane. Three controls (lng of BAV2 DNA, water and 1J.lg of noninfected HeLa DNA) were
included. Size marker (1 kb ladder) was co-electrophoresed and the positions or fragments are
indicated to the left of the figure.
B) Autoradiogram of gel A. peR products were probed with 32p labeled 50-1092 BAV2 E1A
fragment. Legend is same as above.
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4. DISCUSSION and CONCLUSIONS
Adenoviruses are among the most extensively examined gene delivery vectors for human
gene therapy and vaccine development. Most of the Ad vectors constructed for human use are
based on human Ad2 and Ad5 serotypes. This generation of adenoviral vectors, however, suffers
from a number of important limitations preventing the realization of their full potential. One
limitation is the existence of natural immunity against human Ads in the majority of the human
population, thus greatly impairing the administration of Ad-based vectors. Another problem lies
in Ad5' s ability to cause minor respiratory illnesses making it less useful in immunocomprised
recipients. Furthermore, expression of late proteins by AdS vectors induces host cellular immune
response resulting in the loss of transgene expression. These limitations have led several
investigators to seriously consider development of nonpermissive adenovirus vectors. OAV
(Khatri et al., 1997), CAV2 (Klonjkowski et al., 1997) and BAV3 (Mittal et al., 1995) are
currently being studied as potential vectors for use in human gene therapy and vaccine
development.
Similarly, this laboratory is interested in developing nonpermissive BAV2 based vector for
the same purpose. Previous studies on BAV2 vector focused mainly on genetic engineering of
BAV2. However, to use BAV2 in humans other factors must be considered including BAV2 host
range. Thus, the present study focused on the host range of BAV2 by determining the extent of
BAV2 multiplication in HeLa cells.
According to the results depicted in Figures 7 and 8, HeLa cells appeared to be nonpermissive
for BAV2 growth. No detectable amount of infectious virus production was observed in BAV2-
infected HeLa cells during 96 hours of infection. These findings indicated that the cycle's eclipse
period might extend beyond 96 hours or simply that the virus completely fails to replicate. In
fails to replicate.
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In addition, vve sho\ved that the block to VIruS replication could not be
overCOlne by increasing the In01, suggest1ng that viral gene dosage does not affect B_i}.iV2
replicative events in HeLa cells. These res-nIts are not sllrprlslng Slnce adenCfvirllses are highly
species=specific, AlthcHlgh_ rare, heterologolls infections vvith hlunan pi-ds have been doclllnented
111 both cell clliture studies and anilnal -; i11100elS (Romano\¥ski ...... i!./i 1998~ I\!Iartins, 1995),
Interestingly, hovvever, stlldies investigating the host range of non=hull1an adenOVrrtlSes re"vealed
infection in ~ nlunber of hll1nan cell
that Inost of these
found to llndergo
do
. ,"
aoor11ve
..In nlunan cell 1"lilles, In particlllar,
lines (}(hatri ef -,at, 1997;
!(lonjk~o-vvski el (iI., 1997).
To deter1nil1e vvhere the blocl.;::(s) to replication occllrred, the abortive infection of hlllnarl
HeLa cells \vith EllV2 \vas analyzed in considerable detail, Since i\d DJ>ll~,,- replication l11arks the
erld of early transcription and the beginning of late transcrIptIon It provides an ideal l11ark:er f{)r
deterlnining -= ~ "5vvnetner restriction replication at an early late step. ability of
Bi\V2 to undergo [)NA_ synthesis In HeLa vvas detennilled by eXperlJnents llslng
hydroXYllrea to block: [oflnation of endogenous replIcatIon cCHllplexes, The resll1ts shov{n In
1 / indicated that BL~V2 D}~·Pi replicatioll ." 1CllG ocellr In non=perl111ss1ve HeLa cells,
suggestIng the presence of an early blocl~ in Bi\'!2 DN1~~ replicative cycle. p.~ nUlnber of earl~y
e'vents in adenovirus ='"'C'"!~=all.i~ cycle COllld contribute to the defect in DNi\ replication. These include
attacll1nent, .. ~ .. . -I11ternallzatl0n, transport to the 1 .nUCiel and "!earlY gene expreSSIon. Hence, all aspects
of the BitV2 replicative cycle vvere studied in detaiL
The cellular per1111ss1veness and tIssue tropisill of P.i-ds depel1ds 1: = ~ "1largely on tne first step In
adenovirus infection: viral attacll1nent i~iclenovirus attachlnent OCClIrs through the interaction ot
the v'lral fiber=ki~ob protein and higIl=affinity cellular receptors, tor vVhlCh a candidate has
recently been identified for hUlnan i~ids (Ci~R) (Bergelson ef Clr,
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The expreSSIon of these high-af1inity receptors are strongly correlated \vith the susceptibility of
Ine cell infection (Pickles et 1998} Thus, 1t "vas of interest to deterlnine vvhether Bl}.~\/2
abortive infection of HeLa cells is perhaps the result of the defects in Bi\V2 attachlnent to HeLa
cells. thIS 1!ena, vve used radiolabeled V1rllS J,articles ~v delTIOnstrate tilat Bp.~V2 sllccessfully
attaches to the sllrface of HeLa cells. Il1terestingly, hO\Xiev'er, the nUlnber of attached BLA~V2
significantly lovver in HeLa cells com_pared to pennissive JV1TJBK cells (Fig-ures 11 12}
The e?~planation of the reduced nl-Imber of attach_ed Bl}.~V2 particles on HeLa cells 1 11aepenas
,1!Ine 1node ofBl\'/2 attach111ent vvhich can be either throligh :,-:- '1 ~I1Der=receptor . .1nteract10n
or non specific fiber independent rC:llte. Since these exper11nel1ts Viere not designed to reveal the
Inode of Bi~l.-V2 attacrl1nent to HeLa cells se1/eral possible e:xpla!lations are nonetheless proposed
to explain the redllced nllmber of Bl~l-V2 particles on HeLa cell stirface k~eeping in Inind both
rHodes ofB.l\V2 attachlnent to HeI-ota cells:
First, if we aSSlune that HeLa cells do not have high aftInity receptors spec111c fur Bpi-V2 then
the attach1nent of Bi~~V2 fiber to HeLa cells n11ght occur VIa other receptors, such as receptors
fLir human _i\ds: It lIas been , 1!repOftea, 1101liever, that the cell a.ttachlnent domains in adenovirus
fibers varIes consiclerably alnong different adenovirlls sllbgroups, sllggestlng that the binding to
receptors specific to other p.~d subgroups 1S llnlikely (revlcvved by Chroboczek el 7{Ji , 1995}
the liitimate test for this -: .11:.hypotheSIS "VOl-lIcl a cOlnpetition assay In v!hich Bi\V2
attachlnent to HeLa cells is Ineasured fbllowing infection ell HeLa cells vvith an excess of
unlabeled hUlnan 1t\d: If Bl\V2 and hUlnan ill-d C01npete f{}f the saIne receptor Bp~V2 attachrne!1t
to HeLa cells "vvill be cOlnpeted against by increasing alTIOl.lnts of hUlnan -LA~d particles.
p~ltemati\!ely, Bl il.-V2 attachinent to hllinan HeLa cells COllld be l11ediated by senne n_onspecific
processes not involving tIber receptor. This nonspecific attach1!lent 01 adenoviruses has been
preVlollsly doc-umented (Picl.:=les et aI., 1998). For e~xa1nple, l\ct) attaches VIa nonSpeCl!lC
.. -1 ,,-.
~ ! 'i
interactions to both hlunan tracheobronchial epitheliai cells (PD) and rat tracheal epitheliuiTI
(PD) cells: The InaJorlty 01 PiU) attached to the htnnan prj culture surface IS associated \VIth the
abundant glycocaly){ present on the Inicrovilli, sllggestirlg that glycocalyx itself vvas binding
pidS by a fiber=k:nob=independent InechanislTI (Pickles ef al., 1998} Bli:r.-'f<{2 indeed attaches
nonspecifically cells then the affinity '1 ~tlet\veen BLi1~V2 VIrIons ..ana SOlne nonSpeCl:tlc
HeLa cell r:Sllfrace receptors vvill not expected be as high as .. = ,ffilgnt be ,.... -:rOlina naturally on
}\tIDBK cell sllrface, Hence, it is possible that such nonspecifically attached Bl~:r.-V2 virions could
be relTIcrved by nondetergent \vashing vvith PBS in our experilnents: This perhaps explain the
redllced nUlnber ofB_i~iV2 particles associated \tvith HeLa cells sllrface.
possible that Bl~iV2 attached to HeLa :=£-_:--:=~~~~.!.....e..~: an interaction bet\veen fiber and
high-affinity receptors: It has been sho\vn recently that ()l~:r.-'f<V succesSfllll)! adsorbs to a nllinber of
..
numan despite the differerlces in i\d5 fiber dOlnains (f~atri ef 1997).
1 nese reslllts revealed that e)l\'V attachlnent to hlul1an HeLa cells is not a conseqllence of
nonspecific processes but the presence of <=)1\V receptor hlllnan cells. Hence, 1t ~::: possible
that senne receptors orl hlunan cells recogllized norJilllnan P.~d t1ber, Correspondingly,
cells coulet express SOlne receptors that are recognized by Bi\.V2 fiber dOlllain: If this is the case,
a redllced nllmber of attached BAV2 particles in HeLa cells could be explained by the difference
In the expressIon of prilnary receptors for B~1V2 bet\veen HeLa and !vIDBl~ cells: In another
scenarIC}, perhaps the lTIode of fiber i!lteraction v.fith receptors on HeLa cells surface 1S different
,:
tnose on I\!IDBK cells. In other \vords, attachtnent to high specific receptors on
HeLa cells lS lTIllliivalent then the apparent nUlnber of VlfllS sItes IS less than the nUlnber of
receptors. This could be tested by cOlnparing receptor nUlnber to the nUlnber of bound virllS:
second step In • »aaenOVliUS infection involves inteillalization tnediated by interaction
betvveen the i~irg...GIY=i\sp (ROD) lTIotif ill a loop of the penton base and certain classes of
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inte!:,rrins (Bai el aI, 1993; V/icklnan et ai., 1993). Internalization of .Lt\ds can also occur through
scnne nc}nspecific interactions such as pinocytosis as vvas delnonstrated in i\d5 ()f htiinan and rat
PI) cells (Picl~les ef 1998). This nonspecific internalization, hovvever, IS not as efficient
the entry Inediated penton=lntegrln interactions. ()ur analjrses revealed tllat onl)T
attached B.l\V2 internalized HeLa cells 24 rlour post infection 14). ThllS, It IS -= ..posslDle
that Bi1i V2 internalized in HeLa cells by SOlne nonspecific processes, especially if the attachlnent
vvas Inediated by S{)lne fiber il1dependent interactions. If indeed Bl\V2 internalized throligh
penton base=integrin interaction, the relnaining portion of virus that failed to intern.alize COllid be
ex.plained by irrev~ersible binding. Irreversible binding \vould tak.e place if S0111e viral capsid
proteins interact vvith ;;melTIOrane proteIns (belonging or not to receptor) vvith a high
affinity! SllC11 that the resulting complex cannot dissociate llnder physiological conditions, th.en
irreversibly bO'und VIrIons vv'ould nc~t be deliv'ered to the cytopiasin but stay seqllestered in the
plaSlna Inelnbrane ccnnponent (Belin el (Ii., 1993). This \:vas daclunented tn infection of HeLa
cells by i\d2 (Belin ef 1993).
Experilnents on BLt\V2 transport to the nucleI of HeLa cells shovved that 35~;O of the total
entered the "! •nl.IClel of HeLa cells b h_our post=infection 15). In contrast to
adenovirus prodllcti\/e infections In vvhich the transport In the nllcielis 15 cOlupleted \vithin 2
hOllrs post infection (revievved by Shenk, 1996), not all internalized Bi1.i V2 particles reached the
nuclei of HeLa cells \vithin 6 hOllrs. Since \rve did not investigate the accul11ulation of Bl\V2 tn
HeLa nuclei over longer period 01 tIlne 'ive cannot conclude \vith certainty that the transport to
n-uclei is deiayed in this system. One COllId speculate that trle lovv' percentage
Bi\V2 particles is a result of on.e or Inore defects in nllclei transport
nllclei aSSOCIated.
Transport of i\ds to n'uclei of infected cells is preceded by a nUlnber of critical e'vents SllCh as
seqllential clisasselnbly of virion coat proteIns, acidificatic}n and rllpture of the endOSOlne vvhich
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triggers Ad penetration in the cytoplasm. Defects in any of these steps would seriously impair
successful Ad transport to the nucleus. The results in this study clearly showed that a modest
percentage of BAV2 was successfully internalized in HeLa cells. However, neither the precise
location nor the physical integrity of BAV2 particles was demonstrated. In other words, we could
not determine whether all BAV2 particles present in endosomes penetrated the cytoplasm of
HeLa cells and whether or not uncoating of all internalized BAV2 particles occurred within the
endosome in the same fashion as that for human Ads. It was shown previously that under
conditions which inhibit uncoating, virions tend to accumulate in intracellular vesicles (Shenk,
1996). Hence, if uncoating of BAV2 was inhibited in HeLa cells then most of the internalized
virus would remain associated with endosomes and may not reach the nuclei. Furthermore,
although the precise nature of the signal directing the delivery of Ad genome to the nucleus is not
known, several studies have suggested that some protein primary structure motifs such as nuclei
localization signals (NLS) of some viral proteins could playa major role. The major candidates
for the role of directing the adenovirus DNA to the nucleus following uncoating are the pTP and
protein V since they were found to contain a sequence similar to nuclear localization signal
(reviewed by Shenk et al., 1995). Hence, if some BAV2 viral DNA was not associated with pTP
or protein V as a result of impaired uncoating process it would not be successfully transported to
the nucleus of HeLa cells. Further experimentation on the uncoating process of BAV2 in HeLa
cells needs to be conducted in order to answer these questions. For the purposes of the present
study, however, the finding that BAV2 in fact penetrates the nuclei of HeLa cells is significant.
Our experiments on BAV2 E1A transcription clearly demonstrated that HeLa cells did not
support BAV2 E1A transcription (Figure 19). Since E1A products act as a master regulator of
viral gene expression without which the viral cycle cannot proceed successfully, these findings
help explain why no DNA replication was ever observed.
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To answer why BAV2 E1A is not expressed in HeLa cells, we investigated the activity of
BAV2 E1A promoter in HeLa cells. According to our results BAV2 EIA promoter cannot be
activated in HeLa cells, presumably, because host factors do not interact positively with this
promoter (Figures 25 & 26). Upon co-infection with Ad5, however, this promoter is activated
(Figures 27 & 28). Although it is not clear which viral functions are responsible for the
activation of the BAV2 E1A promoter, we speculate that E1 functions of Ad5 play an important
role. That is, human Ad5 E1A functions could trigger the otherwise inactive BAV2 E1A
promoter in HeLa. This is not without a precedent since studies on Ad12 abortive infection of
BHK21 cells have shown that the MLP, which is not active in hamster cells, can be activated
upon infection with permissive Ad2 (Weyer and Doerfler, 1985). They have also demonstrated
that E1 functions of Ad2 have the capacity to activate the MLP of Ad12 DNA. Although E1
proteins are most likely to be involved in the activation ofBAV2 E1A promoter the involvement
of other viral functions in this activation cannot be ruled out. In addition, it is not known whether
these viral functions directly activate the BAV2 promoter, or whether they interact somehow
with cellular factors which in turn activate the BAV2 E1A promoter. What this study found is
that the BAV2 E1A promoter could just be one other promoter known to respond to Ad5 E1A
activation.
Studies on the defects of Ad12 MLP promoter in hamster cells found a mitigator element in
the first intron following the Ad12 MLP. The mitigator somehow blocks proper interaction
among Ad12 proteins, BHK21 protein, and Ad12 DNA to support efficient transcription of the
MLP (Zock and Doerfler, 1990). It would be of interest to determine whether there are some
sequences in BAV2 E1A promoter that affect its activity in HeLa cells such as found for Ad12
MLP.
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Our approach to studying the BAV2 E1A promoter involved the lacZ reporter gene with
BAV2 E1A promoter as its regulatory element. This approach had an advantage in that it allowed
the study to focus on the sequences in question. The disadvantage, however, is that it proved
difficult to demonstrate that the complete E1A promoter was present in the construct. Sequence
analysis of the E1 region (Salmon et al., 1995) suggested the presence ofE1A's TATA box at nt
337. A more recent computer program (SignaIScan) suggested the presence of another TATA
box further downstream. Since our reporter gene construct contained only the first TATA box,
but not the second, it might have an incomplete E1A promoter. Without a function test, either
TATA box could be correct. Future experimentations could resolve the issue.
We have determined that the block in BAV2 E1A transcription in HeLa cells is the reason for
BAV2's failure to undergo viral DNA synthesis. Our prediction that BAV2 might undergo its
viral DNA synthesis in HeLa cells if the block in E1A expression is removed was confirmed by
coinfection experiments involving permissive Ad5. It was shown by these experiments that
BAV2 E1A transcription took place in doubly-infected HeLa cells (Figure 30). This was not
surprising since we have already shown that Ad5 could activate BAV2 E1A promoter. BAV2
DNA synthesis in HeLa cells could also be complemented by Ad5 infection (Figures 31 and 32).
As revealed by densitometric analysis there were not obvious differences in amount of viral DNA
replicated between Ad5 and BAV2 in doubly-infected HeLa cells. We do not know, however, if
all of the early functions of BAV were expressed in this system or whether BAV2 used some
Ad5 proteins for successful viral DNA replication. For example, it would be interesting to study
whether Ad5 DNA polymerase could bind to BAV2 ori and initiate BAV2 DNA replication.
Comparison of AdS and BAV2 binding sites for precursor IP-DNA polymerase (pIP-pol)
revealed very close similarity (Figure 43). Indeed the two sequences differ only in nucleotide at
position 18 (residue C in Ad5 ori; residue G in BAV2 ori). Although it would be possible for
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Ad5 polymerase to bind to BAV2 ori, all other interactions required for the initiation of Ad
replication must still be considered. we still have to keep in mind all other interactions required
for the initiation of Ad replication. For example, since successful initiation of Ad replication
depends largely on DNA polymerase interacting with pTP it would be of interest to study
" whether Ad5 DNA polymerase is capable of interacting with BAV2 TP. To answer all these
questions one must determine if BAV2 expresses its E2 proteins in mixed infection.
Ad5 OR]
nt9 ntI8
CATCATCA ATAATATACC
GTAGTAGTTATTATATGG
BAV2 OR]
nt9 ntI8
CATCATCA ATAATATACG
GTAGTAGTTATTATATGC
Figure 43: Comparison of AdS and BAV2 binding sites for precursor TP-DNA pol
The Ad5/Ad2 sequence of ORI was taken from Van der Vliet (1995), the BAV2 sequence was
taken from Ojkic et ale (1998).
The El region of Ad5 DNA was shown to play an important role in complementation of
impaired BAV2 functions (Figure 37). However, it was also shown that 293 cells were not
capable of complementing BAV2 DNA replication suggesting that the concerted action of more
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than one group of Ad5 functions was essential for BAV2 complementation in HeLa cells (Figure
38). Although our analyses revealed no BAV2 DNA replication upon infection of 293 cells we
cannot conclude with certainty that this was due mainly to the failure of Ad5 E1 to complement
BAV2 impaired functions. First, we have not assessed BAV2 infection of 293 cells in terms of
attachment, internalization and transport to the nuclei. We cannot conclude that BAV2 behaves
in the same fashion upon infection of 293 and HeLa cells since these two cell lines are of
different origin. As indicated before, Ad attachment depends on the presence of specific
receptors on the cell surface. Since cells of different origin express different sets of membrane
proteins not all cells are susceptible to adenovirus infection.
In spite of complementing activity of Ad5 functions on BAV2 DNA replication, intact BAV2
virions were not present. The question on whether this is due to impaired synthesis of structural
proteins or assembly remains unresolved (Figure 36).
Summaries of events resulting from BAV2 infection of permissive MDBK cells and
nonpermissive HeLa cells as well as events resulting from BAV2 infection of Ad5 infected
HeLa cells are presented in a schematic diagrams in Figures 44, 45 and 46. The unresolved
questions and potential focuses of future experimentations are also presented in these diagrams.
If bovine adenovirus will be used in human gene therapy and vaccine development, its
interaction with human cells must be fully understood. This study took the initial steps and found
that BAV2 undergoes abortive infection in human HeLa cells with an early block in DNA
replication. In this abortive infection, BAV2 successfully penetrated HeLa cells and nuclear
transport was evident. However, viral DNA synthesis, early transcription and virus production
were not evident in this infection. Many questions still need to be answered before applying
BAV2 vector in human gene therapy. If BAV2 behaves the same way in all human cell lines as it
does in HeLa cells then the use of BAV2 for human gene therapy and vaccine development looks
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very promising for number of reasons. First, since BAV2 does not replicate in human cells it is
very safe for human use. Second, it is unlikely that humans have preexisting immunity against
BAV2 which makes it an ideal vaccine booster. Third, BAV2 vector would successfully deliver
the foreign genes to human cell nuclei. Fourth, BAV2 infection of human cells does not express
any of its proteins due to defects in E1A transcription. Hence, if BAV2 vector was used in vivo
human gene therapy the risk of the generation of cellular and humoral immune response against
the vector would be greatly reduced if not eliminated.
Several disadvantages of BAV2 vectors in human gene therapy are apparent and include the
possibility that BAV2 would not be able to target all human cells. However, recent studies on
human adenovirus vectors have demonstrated that it is possible to alter the capsid fiber protein by
genetic engineering to direct gene delivery specifically to certain target cell types (reviewed by
Douglas et al., 1997). Perhaps the same technology could be applied to BAy2 vectors to render
them more efficient in targeting human cells.
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